Sandbox coretopics: Difference between revisions
Jump to navigation
Jump to search
Blanked the page |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{| class="wikitable" | |||
! Specialty | |||
! Topic | |||
! Section | |||
! Figure | |||
! Table | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Approach||QRS axis||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Left axis deviation (LAD)||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Right axis deviation (RAD)||–||Bunble branch blocks | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Prolonged QT interval||ECG P Wave Criteria||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Left ventricular hypertrophy (LVH)||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Right ventricular hypertrophy (RVH)||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Ddx of dominant R wave in V1 or V2||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Poor R wave progression (PRWP)||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Pathologic Q waves||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||ST elevation (STE)||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||ST depression (STD)||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||T wave inversion (TWI)||–||– | |||
|- | |||
| Cardiology||[[Electrocardiography]]||Low voltage||–||– | |||
|- | |||
| Cardiology||[[Chest pain]]||Causes of Chest Pain||–||Causes of Chest Pain | |||
|- | |||
| Cardiology||[[Chest pain]]||Initial approach||–||– | |||
|- | |||
| Cardiology||[[Noninvasive evaluation of cad]]||Noninvasive Evaluation of CAD||–||Noninvasive Evaluation of CAD | |||
|- | |||
| Cardiology||[[Noninvasive evaluation of cad]]||Stress testing||–||– | |||
|- | |||
| Cardiology||[[Noninvasive evaluation of cad]]||Test results||–||– | |||
|- | |||
| Cardiology||[[Noninvasive evaluation of cad]]||High-risk test results||–||– | |||
|- | |||
| Cardiology||[[Noninvasive evaluation of cad]]||Myocardial viability||–||– | |||
|- | |||
| Cardiology||[[Noninvasive evaluation of cad]]||CT & MR coronary angio||–||– | |||
|- | |||
| Cardiology||[[Noninvasive evaluation of cad]]||Coronary artery calcium score||–||– | |||
|- | |||
| Cardiology||[[Coronary angiography and revascularization]]||Indications for coronary angiography in stable CAD or asx Pts||–||– | |||
|- | |||
| Cardiology||[[Coronary angiography and revascularization]]||Precath checklist||–||– | |||
|- | |||
| Cardiology||[[Coronary angiography and revascularization]]||Coronary revascularization in stable CAD||–||– | |||
|- | |||
| Cardiology||[[Coronary angiography and revascularization]]||PCI||–||– | |||
|- | |||
| Cardiology||[[Coronary angiography and revascularization]]||Post-PCI complications||–||– | |||
|- | |||
| Cardiology||[[Acute coronary syndromes]]||Ddx (causes of myocardial ischemia/infarction other than atherosclerotic plaque rupture)||–||Spectrum of Acute Coronary Syndromes | |||
|- | |||
| Cardiology||[[Acute coronary syndromes]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Acute coronary syndromes]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Acute coronary syndromes]]||Diagnostic studies||–||Localization of MI | |||
|- | |||
| Cardiology||[[Acute coronary syndromes]]||Prinzmetal’s (variant) angina||–||– | |||
|- | |||
| Cardiology||[[Acute coronary syndromes]]||Approach to triage||–||Likelihood of ACS | |||
|- | |||
| Cardiology||[[Acute coronary syndromes]]||Coronary angiography||–||– | |||
|- | |||
| Cardiology||[[Ua/nstemi]]||Approach to UA/NSTEMI||Approach to UA/NSTEMI||– | |||
|- | |||
| Cardiology||[[Ua/nstemi]]||TIMI Risk Score for UA/NSTEMI||–||TIMI Risk Score for UA/NSTEMI | |||
|- | |||
| Cardiology||[[Ua/nstemi]]||Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI||–||Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI | |||
|- | |||
| Cardiology||[[Ua/nstemi]]||Anticoagulant Therapy for UA/NSTEMI||–||Anticoagulant Therapy for UA/NSTEMI | |||
|- | |||
| Cardiology||[[Stemi]]||Requisite STE (at J point)||–||– | |||
|- | |||
| Cardiology||[[Stemi]]||Reperfusion (“time is muscle”)||–||Fibrinolysis vs Hospital Transfer for Primary PCI | |||
|- | |||
| Cardiology||[[Stemi]]||Primary PCI||–||– | |||
|- | |||
| Cardiology||[[Stemi]]||Fibrinolysis||–||Contraindications to Fibrinolysis | |||
|- | |||
| Cardiology||[[Stemi]]||Non-primary PCI||–||– | |||
|- | |||
| Cardiology||[[Stemi]]||Antiplatelet Therapy for STEMI||–||Antiplatelet Therapy for STEMI | |||
|- | |||
| Cardiology||[[Stemi]]||Anticoagulant Therapy for STEMI||–||Anticoagulant Therapy for STEMI | |||
|- | |||
| Cardiology||[[Stemi]]||Immediate Adjunctive Therapy for STEMI||–||Immediate Adjunctive Therapy for STEMI | |||
|- | |||
| Cardiology||[[Stemi]]||LV failure||–||– | |||
|- | |||
| Cardiology||[[Stemi]]||Inferior MI complications||–||– | |||
|- | |||
| Cardiology||[[Stemi]]||Mechanical complications||–||– | |||
|- | |||
| Cardiology||[[Stemi]]||Post-MI Arrhythmias||–||Other Post-MI Complications | |||
|- | |||
| Cardiology||[[Stemi]]||Prognosis based on Killip Class||–||Prognosis based on Killip Class | |||
|- | |||
| Cardiology||[[Stemi]]||Prognosis based on Forrester Class||–||Prognosis based on Forrester Class | |||
|- | |||
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Risk stratification||–||– | |||
|- | |||
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Medications (barring contraindications)||–||– | |||
|- | |||
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||ICD||–||– | |||
|- | |||
| Cardiology||[[Pre-discharge checklist and long-term post-acs management]]||Risk factors and lifestyle modifications||–||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Rationale||PA Catheter Waveforms||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Indications||–||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Efficacy concerns||–||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Placement||–||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Complications||–||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Intracardiac pressures||–||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Cardiac output||–||– | |||
|- | |||
| Cardiology||[[Pa catheter and tailored therapy]]||Tailored therapy in cardiogenic shock||–||Hemodynamic Profiles of Various Forms of Shock | |||
|- | |||
| Cardiology||[[Heart failure]]||Definitions||–||– | |||
|- | |||
| Cardiology||[[Heart failure]]||History||–||– | |||
|- | |||
| Cardiology||[[Heart failure]]||Functional classification (New York Heart Association class)||–||– | |||
|- | |||
| Cardiology||[[Heart failure]]||Physical exam (“2-minute” hemodynamic profile)||–||– | |||
|- | |||
| Cardiology||[[Heart failure]]||Evaluation for the presence of heart failure||–||– | |||
|- | |||
| Cardiology||[[Heart failure]]||Evaluation of the causes of heart failure||Approach to left-sided heart failure||– | |||
|- | |||
| Cardiology||[[Heart failure]]||Precipitants of acute heart failure||–||– | |||
|- | |||
| Cardiology||[[Heart failure]]||Treatment of acute decompensated heart failure||–||Treatment of acute decompensated heart failure | |||
|- | |||
| Cardiology||[[Heart failure]]||Treatment of advanced heart failure||–||Recommended Chronic Therapy by HF Stage | |||
|- | |||
| Cardiology||[[Heart failure]]||Heart failure with reduced EF (HFrEF)||–||Treatment of HFrEF | |||
|- | |||
| Cardiology||[[Heart failure]]||Heart failure with preserved EF (HFpEF)||–||– | |||
|- | |||
| Cardiology||[[Dilated cardiomyopathy]]||Definition and epidemiology||–||– | |||
|- | |||
| Cardiology||[[Dilated cardiomyopathy]]||Etiologies||–||– | |||
|- | |||
| Cardiology||[[Dilated cardiomyopathy]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Dilated cardiomyopathy]]||Diagnostic studies and workup||–||– | |||
|- | |||
| Cardiology||[[Dilated cardiomyopathy]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Hypertrophic cardiomyopathy]]||Definition and epidemiology||–||– | |||
|- | |||
| Cardiology||[[Hypertrophic cardiomyopathy]]||Pathology||–||– | |||
|- | |||
| Cardiology||[[Hypertrophic cardiomyopathy]]||Pathophysiology||–||– | |||
|- | |||
| Cardiology||[[Hypertrophic cardiomyopathy]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Hypertrophic cardiomyopathy]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Hypertrophic cardiomyopathy]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Hypertrophic cardiomyopathy]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Restrictive cardiomyopathy]]||Definition||–||– | |||
|- | |||
| Cardiology||[[Restrictive cardiomyopathy]]||Etiology||–||– | |||
|- | |||
| Cardiology||[[Restrictive cardiomyopathy]]||Pathology & pathophysiology||–||– | |||
|- | |||
| Cardiology||[[Restrictive cardiomyopathy]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Restrictive cardiomyopathy]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Restrictive cardiomyopathy]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Restrictive cardiomyopathy]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Aortic stenosis]]||Etiology||–||– | |||
|- | |||
| Cardiology||[[Aortic stenosis]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Aortic stenosis]]||Physical exam||Hemodynamics of Aortic Stenosis||– | |||
|- | |||
| Cardiology||[[Aortic stenosis]]||Diagnostic studies||–||Classification of Aortic Stenosis | |||
|- | |||
| Cardiology||[[Aortic stenosis]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Aortic insufficiency]]||Etiology||–||– | |||
|- | |||
| Cardiology||[[Aortic insufficiency]]||Clinical manifestations||–||Classic Eponymous Signs in Chronic Aortic Insufficiency | |||
|- | |||
| Cardiology||[[Aortic insufficiency]]||Physical exam||Hemodynamics of Aortic Insufficiency||– | |||
|- | |||
| Cardiology||[[Aortic insufficiency]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Aortic insufficiency]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Mitral regurgitation]]||Etiology||–||– | |||
|- | |||
| Cardiology||[[Mitral regurgitation]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Mitral regurgitation]]||Physical exam||Hemodynamics of Mitral Regurgitation||– | |||
|- | |||
| Cardiology||[[Mitral regurgitation]]||Diagnostic studies||–||Classification of Mitral Regurgitation | |||
|- | |||
| Cardiology||[[Mitral regurgitation]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Mitral stenosis]]||Etiology||–||– | |||
|- | |||
| Cardiology||[[Mitral stenosis]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Mitral stenosis]]||Physical exam||Hemodynamics of Mitral Stenosis||– | |||
|- | |||
| Cardiology||[[Mitral stenosis]]||Diagnostic studies||–||Classification of Mitral Stenosis | |||
|- | |||
| Cardiology||[[Mitral stenosis]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Mitral valve prolapse]]||Definition and etiology||–||– | |||
|- | |||
| Cardiology||[[Mitral valve prolapse]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Mitral valve prolapse]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Mitral valve prolapse]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Tricuspid regurgitation]]||Tricuspid regurgitation||–||– | |||
|- | |||
| Cardiology||[[Prosthetic heart valves]]||Mechanical||Superior View of Heart Valves||– | |||
|- | |||
| Cardiology||[[Prosthetic heart valves]]||Bioprosthetic||–||– | |||
|- | |||
| Cardiology||[[Prosthetic heart valves]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Prosthetic heart valves]]||Anticoagulation & antiplatelet therapy||–||Periprocedural Bridging of Anticoagulation in Pts with MV | |||
|- | |||
| Cardiology||[[Prosthetic heart valves]]||Correction of overanticoagulation||–||– | |||
|- | |||
| Cardiology||[[Prosthetic heart valves]]||Endocarditis prophylaxis||–||– | |||
|- | |||
| Cardiology||[[Prosthetic heart valves]]||Complications||–||– | |||
|- | |||
| Cardiology||[[Pericardial disease]]||Anatomy||–||– | |||
|- | |||
| Cardiology||[[Pericardial disease]]||Disease states||–||– | |||
|- | |||
| Cardiology||[[Pericarditis and pericardial effusion]]||Etiology||–||Etiologies of Acute Pericarditis | |||
|- | |||
| Cardiology||[[Pericarditis and pericardial effusion]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Pericarditis and pericardial effusion]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Pericarditis and pericardial effusion]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Pericarditis and pericardial effusion]]||Workup for effusion||–||– | |||
|- | |||
| Cardiology||[[Pericarditis and pericardial effusion]]||Treatment of pericarditis||–||– | |||
|- | |||
| Cardiology||[[Pericardial tamponade]]||Etiology||–||– | |||
|- | |||
| Cardiology||[[Pericardial tamponade]]||Pathophysiology||–||– | |||
|- | |||
| Cardiology||[[Pericardial tamponade]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Pericardial tamponade]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Pericardial tamponade]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Pericardial tamponade]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Constrictive pericarditis]]||Etiology||–||Constrictive Pericarditis vs Restrictive Cardiomyopathy | |||
|- | |||
| Cardiology||[[Constrictive pericarditis]]||Pathophysiology||–||– | |||
|- | |||
| Cardiology||[[Constrictive pericarditis]]||Clinical manifestations||–||– | |||
|- | |||
| Cardiology||[[Constrictive pericarditis]]||Physical exam||–||– | |||
|- | |||
| Cardiology||[[Constrictive pericarditis]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Constrictive pericarditis]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Hypertension]]||Classification||–||JNC VII Classification of Hypertension | |||
|- | |||
| Cardiology||[[Hypertension]]||Epidemiology||–||– | |||
|- | |||
| Cardiology||[[Hypertension]]||Etiologies||–||Secondary Causes of Hypertension | |||
|- | |||
| Cardiology||[[Hypertension]]||Standard workup||–||– | |||
|- | |||
| Cardiology||[[Hypertension]]||Complications of HTN||–||– | |||
|- | |||
| Cardiology||[[Hypertension]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Hypertensive crises]]||Definitions||–||– | |||
|- | |||
| Cardiology||[[Hypertensive crises]]||Precipitants||–||– | |||
|- | |||
| Cardiology||[[Hypertensive crises]]||Treatment||–||Drugs for Hypertensive Crises | |||
|- | |||
| Cardiology||[[Aortic aneurysms]]||Definitions||–||– | |||
|- | |||
| Cardiology||[[Aortic aneurysms]]||Epidemiology||–||– | |||
|- | |||
| Cardiology||[[Aortic aneurysms]]||Pathophysiology||–||– | |||
|- | |||
| Cardiology||[[Aortic aneurysms]]||Screening||–||– | |||
|- | |||
| Cardiology||[[Aortic aneurysms]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Aortic aneurysms]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Acute aortic syndromes]]||Definitions||–||– | |||
|- | |||
| Cardiology||[[Acute aortic syndromes]]||Classification||–||– | |||
|- | |||
| Cardiology||[[Acute aortic syndromes]]||Risk factors||–||– | |||
|- | |||
| Cardiology||[[Acute aortic syndromes]]||Clinical manifestations||–||Clinical Manifestations and Physical Exam of Acute Aortic Syndromes | |||
|- | |||
| Cardiology||[[Acute aortic syndromes]]||Diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Acute aortic syndromes]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Acute aortic syndromes]]||Complications||–||– | |||
|- | |||
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Sinus bradycardia (SB) ||–||– | |||
|- | |||
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Sick sinus syndrome (SSS)||–||– | |||
|- | |||
| Cardiology||[[Bradycardias, av block, and av dissociation]]||AV Block||–||Classification of AV Block | |||
|- | |||
| Cardiology||[[Bradycardias, av block, and av dissociation]]||AV Dissociation||–||– | |||
|- | |||
| Cardiology||[[Bradycardias, av block, and av dissociation]]||Temporary pacing wires||–||– | |||
|- | |||
| Cardiology||[[Supraventricular tachycardias]]||Approach||–||Approach to SVT | |||
|- | |||
| Cardiology||[[Supraventricular tachycardias]]||Etiology||–||Common Etiologies of SVT | |||
|- | |||
| Cardiology||[[Supraventricular tachycardias]]||Diagnosis||–||Diagnosis of SVT | |||
|- | |||
| Cardiology||[[Supraventricular tachycardias]]||Treatment||–||Treatment of SVT | |||
|- | |||
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Definitions||Delta wave of WPW Syndrome||– | |||
|- | |||
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Classic tachycardias of WPW||–||– | |||
|- | |||
| Cardiology||[[Accessory pathways (wolff-parkinson-white)]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Wide-complex tachycardias]]||Etiology||–||– | |||
|- | |||
| Cardiology||[[Wide-complex tachycardias]]||Monomorphic ventricular tachycardia (MMVT)||Epsilon wave in ARVD||– | |||
|- | |||
| Cardiology||[[Wide-complex tachycardias]]||Polymorphic ventricular tachycardia (PMVT)||ECG of Brugada Syndrome||– | |||
|- | |||
| Cardiology||[[Wide-complex tachycardias]]||Diagnostic clues that favor VT (assume until proven o/w)||–||– | |||
|- | |||
| Cardiology||[[Wide-complex tachycardias]]||Long-term management||–||– | |||
|- | |||
| Cardiology||[[Atrial fibrillation]]||Classification||–||– | |||
|- | |||
| Cardiology||[[Atrial fibrillation]]||Epidemiology and etiologies||–||– | |||
|- | |||
| Cardiology||[[Atrial fibrillation]]||Evaluation||–||Approach to Acute AF | |||
|- | |||
| Cardiology||[[Atrial fibrillation]]||Strategies for recurrent AF||–||Rate Control for AF | |||
|- | |||
| Cardiology||[[Atrial fibrillation]]||Cardioversion||–||Antiarrhythmic Drugs for AF | |||
|- | |||
| Cardiology||[[Atrial fibrillation]]||Nonpharmacologic therapy||–||– | |||
|- | |||
| Cardiology||[[Atrial fibrillation]]||Oral anticoagulation||–||Novel Oral Anticoagulants for Nonvalvular AF | |||
|- | |||
| Cardiology||[[Syncope]]||Definition||–||– | |||
|- | |||
| Cardiology||[[Syncope]]||Etiologies||–||– | |||
|- | |||
| Cardiology||[[Syncope]]||Workup||Approach to Syncope||– | |||
|- | |||
| Cardiology||[[Syncope]]||Other diagnostic studies||–||– | |||
|- | |||
| Cardiology||[[Syncope]]||High-risk features||–||– | |||
|- | |||
| Cardiology||[[Syncope]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Syncope]]||Prognosis||–||– | |||
|- | |||
| Cardiology||[[Intracardiac devices]]||Pacemaker Code||–||Pacemaker Code | |||
|- | |||
| Cardiology||[[Intracardiac devices]]||Common Pacing Modes||–||Common Pacing Modes | |||
|- | |||
| Cardiology||[[Intracardiac devices]]||Indications for Permanent Pacing||–||Indications for Permanent Pacing | |||
|- | |||
| Cardiology||[[Intracardiac devices]]||Permanent Pacemaker Complications||–||Permanent Pacemaker Complications | |||
|- | |||
| Cardiology||[[Intracardiac devices]]||Cardiac resynch therapy (CRT)/Biventricular (BiV) pacing||–||– | |||
|- | |||
| Cardiology||[[Intracardiac devices]]||Implantable cardiac defibrillator (ICD)||–||– | |||
|- | |||
| Cardiology||[[Intracardiac devices]]||Device infection||–||– | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Clinical Assessment||–||Clinical Assessment | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Surgery-Specific Risk||–||Surgery-Specific Risk | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Functional Capacity||–||Functional Capacity | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Noninvasive Testing Result||–||Noninvasive Testing Result | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Preoperative evaluation||ACC/AHA approach to preoperative cardiovascular evaluation for noncardiac surgery||– | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Preoperative testing and assessment||–||– | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Pre- & perioperative management||–||– | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Perioperative β-blocker||–||– | |||
|- | |||
| Cardiology||[[Cardiac risk assessment for noncardiac surgery]]||Postoperative monitoring||–||– | |||
|- | |||
| Cardiology||[[Peripheral artery disease]]||Clinical features||–||– | |||
|- | |||
| Cardiology||[[Peripheral artery disease]]||Diagnosis||–||– | |||
|- | |||
| Cardiology||[[Peripheral artery disease]]||Treatment||–||– | |||
|- | |||
| Cardiology||[[Peripheral artery disease]]||Acute limb ischemia (ALI)||–||– | |||
|- | |||
| Pulmonary||[[Dyspnea]]||Etiologies||–||Etiologies of Dyspnea | |||
|- | |||
| Pulmonary||[[Dyspnea]]||Evaluation||–||– | |||
|- | |||
| Pulmonary||[[Pulmonary function tests]]||Approach to abnormal PFTs||Approach to abnormal PFTs||– | |||
|- | |||
| Pulmonary||[[Asthma]]||Definition and epidemiology||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||Clinical manifestations||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||Physical examination||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||Diagnostic studies||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||Ddx||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||“Asthma plus” syndromes||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||“Reliever” medications||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||“Controller” meds||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||Other||–||– | |||
|- | |||
| Pulmonary||[[Asthma]]||Principles of treatment||–||Asthma Stepwise Therapy | |||
|- | |||
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||Evaluation||–||Severity of Asthma Exacerbation | |||
|- | |||
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||Initial treatment ||Disposition of patients after initial treatment of asthma exacerbation||– | |||
|- | |||
| Pulmonary||[[Asthma exacerbation resident survival guide|Asthma exacerbation]]||ICU-level care||–||– | |||
|- | |||
| Pulmonary||[[Anaphylaxis]]||Definition and pathophysiology||–||– | |||
|- | |||
| Pulmonary||[[Anaphylaxis]]||Diagnosis||–||– | |||
|- | |||
| Pulmonary||[[Anaphylaxis]]||Treatment||–||– | |||
|- | |||
| Pulmonary||[[Anaphylaxis]]||Disposition||–||– | |||
|- | |||
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Definition and epidemiology||–||Emphysema vs Chronic Bronchitis | |||
|- | |||
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Pathogenesis||–||– | |||
|- | |||
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Clinical manifestations||–||– | |||
|- | |||
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Diagnostic studies||–||– | |||
|- | |||
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Chronic treatment||–||– | |||
|- | |||
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Staging and prognosis||–||COPD Staging and Recommended Therapies by GOLD Criteria | |||
|- | |||
| Pulmonary||[[Chronic obstructive pulmonary disease]]||Exacerbation||–||COPD Exacerbation Treatment | |||
|- | |||
| Pulmonary||[[Hemoptysis]]||Definition and pathophysiology||–||– | |||
|- | |||
| Pulmonary||[[Hemoptysis]]||Etiologies||–||Etiologies of Hemoptysis | |||
|- | |||
| Pulmonary||[[Hemoptysis]]||Diagnostic workup||–||– | |||
|- | |||
| Pulmonary||[[Hemoptysis]]||Treatment||–||– | |||
|- | |||
| Pulmonary||[[Bronchiectasis]]||Definition and epidemiology||–||– | |||
|- | |||
| Pulmonary||[[Bronchiectasis]]||Initial workup||–||Etiologies of Bronchiectasis | |||
|- | |||
| Pulmonary||[[Bronchiectasis]]||Treatment||–||– | |||
|- | |||
| Pulmonary||[[Solitary pulmonary nodule]]||Principles||–||Etiologies of SPN | |||
|- | |||
| Pulmonary||[[Solitary pulmonary nodule]]||Initial evaluation||–||– | |||
|- | |||
| Pulmonary||[[Solitary pulmonary nodule]]||Diagnostic studies||–||– | |||
|- | |||
| Pulmonary||[[Solitary pulmonary nodule]]||Management||–||– | |||
|- | |||
| Pulmonary||[[Obstructive sleep apnea]]||Definition and pathophysiology||–||– | |||
|- | |||
| Pulmonary||[[Obstructive sleep apnea]]||Clinical manifestations||–||– | |||
|- | |||
| Pulmonary||[[Obstructive sleep apnea]]||Diagnosis and treatment||–||– | |||
|- | |||
| Pulmonary||[[Interstitial lung disease]]||Workup of ILD||–||– | |||
|- | |||
| Pulmonary||[[Interstitial lung disease]]||Etiologies of ILD||–||Clinical Manifestations of Sarcoidosis | |||
|- | |||
| Pulmonary||[[Interstitial lung disease]]||Idiopathic Interstitial Pneumonias||–||Classification of Idiopathic Interstitial Pneumonia | |||
|- | |||
| Pulmonary||[[Pleural effusion]]||Pathophysiology||–||– | |||
|- | |||
| Pulmonary||[[Pleural effusion]]||Transudates||–||– | |||
|- | |||
| Pulmonary||[[Pleural effusion]]||Exudates||–||– | |||
|- | |||
| Pulmonary||[[Pleural effusion]]||Diagnostic studies||–||Characteristics of Pleural Fluid | |||
|- | |||
| Pulmonary||[[Pleural effusion]]||Treatment||–||– | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Definitions||–||– | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Risk factors||–||Thromboprophylaxis | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Clinical manifestations—DVT||–||Simplified Wells Pretest Probability Scoring for DVT | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Diagnostic studies—DVT||Approach to Suspected DVT||– | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Clinical manifestations—PE||–||Simplified Wells Pretest Probability Scoring for PE | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Diagnostic studies—PE ||Approach to Suspected PE using CTA||– | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Workup for idiopathic VTE||–||– | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Risk stratification for Pts with PE||–||– | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Treatment of VTE||–||– | |||
|- | |||
| Pulmonary||[[Venous thromboembolism]]||Complications & prognosis||–||– | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Pathobiology||–||Etiologies of Pulmonary Hypertension | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Clinical manifestations||–||– | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Physical exam||–||– | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Diagnostic studies & workup||–||– | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Treatment||Treatment of PAH||– | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Treatment||–||Vasoactive Agents for PAH | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Management of ICU patient||–||– | |||
|- | |||
| Pulmonary||[[Pulmonary hypertension]]||Prognosis||–||– | |||
|- | |||
| Pulmonary||[[Respiratory failure]]||Hypoxia||Workup of acute hypoxemia||– | |||
|- | |||
| Pulmonary||[[Respiratory failure]]||Chemical Causes of Cellular Hypoxia||–||Chemical Causes of Cellular Hypoxia | |||
|- | |||
| Pulmonary||[[Respiratory failure]]||Hypercapnia||–||Etiologies of Hypercapnia | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Indications||–||– | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Choosing settings||–||– | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Pick Ventilator Mode||–||Pick Ventilator Mode | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Choose Volume Targeted or Pressure Targeted||–||Choose Volume Targeted or Pressure Targeted | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Set Remaining Variables||–||Set Remaining Variables | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Initial Settings||–||Initial Settings | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Noninvasive CPAP/Ventilation||–||Noninvasive CPAP/Ventilation | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Tailoring the ventilator settings||–||– | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Acute ventilatory deterioration||Approach to acute ventilatory deterioration||– | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Weaning from the ventilator||–||– | |||
|- | |||
| Pulmonary||[[Mechanical ventilation]]||Complications||–||– | |||
|- | |||
| Pulmonary||[[Acute respiratory distress syndrome]]||New “Berlin” definition||–||– | |||
|- | |||
| Pulmonary||[[Acute respiratory distress syndrome]]||Pathophysiology||–||Etiologies of ARDS | |||
|- | |||
| Pulmonary||[[Acute respiratory distress syndrome]]||Treatment||–||Ventilator Strategies by VILI Mechanisms | |||
|- | |||
| Pulmonary||[[Acute respiratory distress syndrome]]||Prognosis||–||– | |||
|- | |||
| Pulmonary||[[Sepsis]]||Definitions||–||Sepsis Definitions | |||
|- | |||
| Pulmonary||[[Sepsis]]||Fluids & vasoactive drugs||–||– | |||
|- | |||
| Pulmonary||[[Sepsis]]||Antibiotics||–||– | |||
|- | |||
| Pulmonary||[[Sepsis]]||Steroids||–||– | |||
|- | |||
| Pulmonary||[[Sepsis]]||Activated protein C||–||– | |||
|- | |||
| Pulmonary||[[Sepsis]]||Intensive glycemic control||–||– | |||
|- | |||
| Gastroenterology||[[Dysphagia]]||Definitions||Etiologies of and approach to dysphagia||– | |||
|- | |||
| Gastroenterology||[[Achalasia]]||Achalasia||–||– | |||
|- | |||
| Gastroenterology||[[Other esophageal disorders]]||Other esophageal disorders||–||– | |||
|- | |||
| Gastroenterology||[[Gastroesophageal reflux disease]]||Pathophysiology||–||– | |||
|- | |||
| Gastroenterology||[[Gastroesophageal reflux disease]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Gastroesophageal reflux disease]]||Diagnosis||–||– | |||
|- | |||
| Gastroenterology||[[Gastroesophageal reflux disease]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Gastroesophageal reflux disease]]||Complications||–||– | |||
|- | |||
| Gastroenterology||[[Dyspepsia]]||Definition||–||– | |||
|- | |||
| Gastroenterology||[[Dyspepsia]]||Etiologies||–||– | |||
|- | |||
| Gastroenterology||[[Dyspepsia]]||Treatment of functional dyspepsia||–||– | |||
|- | |||
| Gastroenterology||[[Peptic ulcer disease]]||Epidemiology & etiologies||–||– | |||
|- | |||
| Gastroenterology||[[Peptic ulcer disease]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Peptic ulcer disease]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Peptic ulcer disease]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Peptic ulcer disease]]||Prophylaxis if ASA/NSAID required||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Definition||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Etiologies of upper GI bleed (UGIB)||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Etiologies of lower GI bleed (LGIB)||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Initial management||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Workup||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Treatment of GIB by Etiologies||–||Treatment of GIB by Etiologies | |||
|- | |||
| Gastroenterology||[[Gastrointestinal bleeding]]||Obscure GIB||–||– | |||
|- | |||
| Gastroenterology||[[Acute diarrhea]]||Infectious Etiologies of Acute Diarrhea||–||Infectious Etiologies of Acute Diarrhea | |||
|- | |||
| Gastroenterology||[[Acute diarrhea]]||Evaluation||–||– | |||
|- | |||
| Gastroenterology||[[Acute diarrhea]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Pathogenesis||–||– | |||
|- | |||
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Diagnosis||–||– | |||
|- | |||
| Gastroenterology||[[Clostridium difficile-associated diarrhea]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Chronic diarrhea]]||Medications||–||– | |||
|- | |||
| Gastroenterology||[[Chronic diarrhea]]||Osmotic||–||– | |||
|- | |||
| Gastroenterology||[[Chronic diarrhea]]||Malabsorption||–||– | |||
|- | |||
| Gastroenterology||[[Chronic diarrhea]]||Inflammatory||–||– | |||
|- | |||
| Gastroenterology||[[Chronic diarrhea]]||Secretory||–||– | |||
|- | |||
| Gastroenterology||[[Chronic diarrhea]]||Motility||–||– | |||
|- | |||
| Gastroenterology||[[Chronic diarrhea]]||Workup of chronic diarrhea||Workup of chronic diarrhea||– | |||
|- | |||
| Gastroenterology||[[Constipation and adynamic ileus]]||Constipation||–||– | |||
|- | |||
| Gastroenterology||[[Constipation and adynamic ileus]]||Acute pseudo-obstruction (adynamic ileus)||–||– | |||
|- | |||
| Gastroenterology||[[Nutrition in hospitalized patients]]||Pathophysiology||–||– | |||
|- | |||
| Gastroenterology||[[Nutrition in hospitalized patients]]||Critical illness||–||– | |||
|- | |||
| Gastroenterology||[[Nutrition in hospitalized patients]]||End-stage liver disease||–||– | |||
|- | |||
| Gastroenterology||[[Nutrition in hospitalized patients]]||Refeeding syndrome||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulosis]]||Definition & pathobiology||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulosis]]||Epidemiology||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulosis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulitis]]||Pathophysiology||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulitis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulitis]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulitis]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Diverticulitis]]||Prevention||–||– | |||
|- | |||
| Gastroenterology||[[Diverticular hemorrhage]]||Pathophysiology||–||– | |||
|- | |||
| Gastroenterology||[[Diverticular hemorrhage]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Diverticular hemorrhage]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Diverticular hemorrhage]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Inflammatory bowel disease]]||Definition||–||– | |||
|- | |||
| Gastroenterology||[[Inflammatory bowel disease]]||Epidemiology & pathophysiology||–||– | |||
|- | |||
| Gastroenterology||[[Ulcerative colitis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Ulcerative colitis]]||Diagnosis||–||– | |||
|- | |||
| Gastroenterology||[[Ulcerative colitis]]||Complications||–||– | |||
|- | |||
| Gastroenterology||[[Ulcerative colitis]]||Prognosis||–||– | |||
|- | |||
| Gastroenterology||[[Crohn's disease]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Crohn's disease]]||Diagnosis||–||– | |||
|- | |||
| Gastroenterology||[[Crohn's disease]]||Complications||–||– | |||
|- | |||
| Gastroenterology||[[Crohn's disease]]||Prognosis||–||– | |||
|- | |||
| Gastroenterology||[[Management of inflammatory bowel disease]]||Initial evaluation||–||IBD Induction of Remission | |||
|- | |||
| Gastroenterology||[[Management of inflammatory bowel disease]]||Goals of treatment||–||IBD Maintenance of Remission | |||
|- | |||
| Gastroenterology||[[Management of inflammatory bowel disease]]||Complications of therapy||–||– | |||
|- | |||
| Gastroenterology||[[Management of inflammatory bowel disease]]||Cancer screening||–||– | |||
|- | |||
| Gastroenterology||[[Acute mesenteric ischemia]]||Etiologies||–||– | |||
|- | |||
| Gastroenterology||[[Acute mesenteric ischemia]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Acute mesenteric ischemia]]||Physical exam||–||– | |||
|- | |||
| Gastroenterology||[[Acute mesenteric ischemia]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Acute mesenteric ischemia]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Acute mesenteric ischemia]]||Prognosis||–||– | |||
|- | |||
| Gastroenterology||[[Ischemic colitis]]||Definition & pathophysiology||–||– | |||
|- | |||
| Gastroenterology||[[Ischemic colitis]]||Clinical manifestations, diagnosis, & treatment||–||– | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Pathogenesis||–||– | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Etiologies||–||– | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Physical exam||–||– | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Complications||–||Ranson's Criteria | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Prognosis||–||Pancreatitis Prognosis by Ranson's Criteria | |||
|- | |||
| Gastroenterology||[[Pancreatitis]]||Chronic Pancreatitis||–||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Tests of hepatocellular injury or cholestasis||–||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Tests of hepatic function||–||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Patterns of liver injury||–||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with hepatocellular pattern||Approach to abnormal liver tests with hepatocellular pattern||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with cholestatic pattern||Approach to abnormal liver tests with cholestatic pattern||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with isolated hyperbilirubinemia||Approach to abnormal liver tests with isolated hyperbilirubinemia||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests with infiltrated pattern||Approach to abnormal liver tests with infiltrated pattern||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Abnormal liver tests in asymptomatic patients||–||– | |||
|- | |||
| Gastroenterology||[[Abnormal liver tests]]||Common medications that cause abnormal liver tests||–||Common medications that cause abnormal liver tests | |||
|- | |||
| Gastroenterology||[[Viral hepatitis]]||Hepatitis A||–||– | |||
|- | |||
| Gastroenterology||[[Viral hepatitis]]||Hepatitis B||Serologic Diagnosis of Hepatitis B||– | |||
|- | |||
| Gastroenterology||[[Viral hepatitis]]||Hepatitis B||–||Serology of Hepatitis B | |||
|- | |||
| Gastroenterology||[[Viral hepatitis]]||Hepatitis C||–||– | |||
|- | |||
| Gastroenterology||[[Viral hepatitis]]||Hepatitis D||–||– | |||
|- | |||
| Gastroenterology||[[Viral hepatitis]]||Hepatitis E||–||– | |||
|- | |||
| Gastroenterology||[[Viral hepatitis]]||Other Viruses||–||– | |||
|- | |||
| Gastroenterology||[[Autoimmune hepatitis]]||Classification||–||– | |||
|- | |||
| Gastroenterology||[[Autoimmune hepatitis]]||Diagnosis and treatment||–||– | |||
|- | |||
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Alcoholic hepatitis||–||– | |||
|- | |||
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Acetaminophen hepatotoxicity||–||– | |||
|- | |||
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Ischemic hepatitis||–||– | |||
|- | |||
| Gastroenterology||[[Other causes of hepatitis or hepatotoxicity]]||Nonalcoholic fatty liver disease||–||– | |||
|- | |||
| Gastroenterology||[[Acute liver failure]]||Definition||–||– | |||
|- | |||
| Gastroenterology||[[Acute liver failure]]||Etiology||–||– | |||
|- | |||
| Gastroenterology||[[Acute liver failure]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Acute liver failure]]||Workup||–||– | |||
|- | |||
| Gastroenterology||[[Acute liver failure]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Acute liver failure]]||Prognosis||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Definition||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Etiologies||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Physical exam||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Laboratory studies||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Workup||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Ascites||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Spontaneous bacterial peritonitis||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Gastroesophageal varices ± UGIB||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Portosystemic encephalopathy (PSE)||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Hepatorenal syndrome (HRS)||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Hepatocellular carcinoma (HCC)||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Other complications||–||– | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Prognosis||–||Modified Child-Turcotte-Pugh Scoring System | |||
|- | |||
| Gastroenterology||[[Cirrhosis]]||Liver transplantation||–||– | |||
|- | |||
| Gastroenterology||[[Other etiologies of cirrhosis]]||Hemochromatosis||–||– | |||
|- | |||
| Gastroenterology||[[Other etiologies of cirrhosis]]||Wilson's disease||–||– | |||
|- | |||
| Gastroenterology||[[Other etiologies of cirrhosis]]||ɑ1-antitrypsin deficiency||–||– | |||
|- | |||
| Gastroenterology||[[Other etiologies of cirrhosis]]||Primary biliary cirrhosis (PBC)||–||– | |||
|- | |||
| Gastroenterology||[[Other etiologies of cirrhosis]]||Primary sclerosing cholangitis (PSC)||–||– | |||
|- | |||
| Gastroenterology||[[Hepatic vascular disease]]||Portal vein thrombosis||–||– | |||
|- | |||
| Gastroenterology||[[Hepatic vascular disease]]||Budd-Chiari syndrome||–||– | |||
|- | |||
| Gastroenterology||[[Hepatic vascular disease]]||Sinusoidal obstruction syndrome||Hepatic vasculature||– | |||
|- | |||
| Gastroenterology||[[Ascites]]||Pathophysiology||–||Etiologies of Ascites | |||
|- | |||
| Gastroenterology||[[Ascites]]||Symptoms||–||– | |||
|- | |||
| Gastroenterology||[[Ascites]]||Evaluation||–||– | |||
|- | |||
| Gastroenterology||[[Ascites]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Ascites]]||Bacterial peritonitis||–||Ascites in Bacterial peritonitis | |||
|- | |||
| Gastroenterology||[[Cholelithiasis]]||Epidemiology & pathogenesis||–||– | |||
|- | |||
| Gastroenterology||[[Cholelithiasis]]||Types of gallstones||–||– | |||
|- | |||
| Gastroenterology||[[Cholelithiasis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Cholelithiasis]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Cholelithiasis]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Cholelithiasis]]||Complications||–||– | |||
|- | |||
| Gastroenterology||[[Cholecystitis]]||Pathogenesis||–||– | |||
|- | |||
| Gastroenterology||[[Cholecystitis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Cholecystitis]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Cholecystitis]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Cholecystitis]]||Complications||–||– | |||
|- | |||
| Gastroenterology||[[Choledocholithiasis]]||Definition||–||– | |||
|- | |||
| Gastroenterology||[[Choledocholithiasis]]||Epidemiology||–||– | |||
|- | |||
| Gastroenterology||[[Choledocholithiasis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Choledocholithiasis]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Choledocholithiasis]]||Treatment||–||– | |||
|- | |||
| Gastroenterology||[[Choledocholithiasis]]||Complications||–||– | |||
|- | |||
| Gastroenterology||[[Cholangitis]]||Definition & etiologies||–||– | |||
|- | |||
| Gastroenterology||[[Cholangitis]]||Clinical manifestations||–||– | |||
|- | |||
| Gastroenterology||[[Cholangitis]]||Diagnostic studies||–||– | |||
|- | |||
| Gastroenterology||[[Cholangitis]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Acid-base disturbances]]||Consequences of Severe Acid-Base Disturbances||–||Consequences of Severe Acid-Base Disturbances | |||
|- | |||
| Nephrology||[[Acid-base disturbances]]||Workup||–||Acid-Base Disturbances | |||
|- | |||
| Nephrology||[[Acid-base disturbances]]||Compensation for Acid-Base Disturbances||–||Compensation for Acid-Base Disturbances | |||
|- | |||
| Nephrology||[[Acid-base disturbances]]||Acid-base nomogram||Acid-base nomogram||– | |||
|- | |||
| Nephrology||[[Metabolic acidosis]]||Initial workup||Approach to metabolic acidosis||– | |||
|- | |||
| Nephrology||[[Metabolic acidosis]]||Etiologies of AG metabolic acidosis||–||Etiologies of AG metabolic acidosis | |||
|- | |||
| Nephrology||[[Metabolic acidosis]]||Workup for AG metabolic acidosis||–||Manifestations of ingestions causing AG metabolic acidosis | |||
|- | |||
| Nephrology||[[Metabolic acidosis]]||Workup for non-AG metabolic acidosis ||–||Etiologies of non-AG metabolic acidosis | |||
|- | |||
| Nephrology||[[Metabolic acidosis]]||Renal tubular acidosis||–||Renal tubular acidosis | |||
|- | |||
| Nephrology||[[Metabolic acidosis]]||Treatment of severe metabolic acidosis||–||– | |||
|- | |||
| Nephrology||[[Metabolic alkalosis]]||Pathophysiology||–||– | |||
|- | |||
| Nephrology||[[Metabolic alkalosis]]||Workup||Approach to metabolic alkalosis||– | |||
|- | |||
| Nephrology||[[Metabolic alkalosis]]||Etiologies of metabolic alkalosis||–||Etiologies of metabolic alkalosis | |||
|- | |||
| Nephrology||[[Metabolic alkalosis]]||Treatment of severe metabolic alkalosis||–||– | |||
|- | |||
| Nephrology||[[Respiratory acidosis]]||Respiratory Acidosis||–||– | |||
|- | |||
| Nephrology||[[Respiratory alkalosis]]||Respiratory Alkalosis||–||– | |||
|- | |||
| Nephrology||[[Hyponatremia]]||Pathophysiology||Approach to hyponatremia||– | |||
|- | |||
| Nephrology||[[Hyponatremia]]||Workup||–||– | |||
|- | |||
| Nephrology||[[Hyponatremia]]||Hypovolemic hypotonic hyponatremia ||–||– | |||
|- | |||
| Nephrology||[[Hyponatremia]]||Euvolemic hypotonic hyponatremia||–||– | |||
|- | |||
| Nephrology||[[Hyponatremia]]||Hypervolemic hypotonic hyponatremia||–||– | |||
|- | |||
| Nephrology||[[Hyponatremia]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Hypernatremia]]||Pathophysiology||Approach to hypernatremia||– | |||
|- | |||
| Nephrology||[[Hypernatremia]]||Workup||–||– | |||
|- | |||
| Nephrology||[[Hypernatremia]]||Extrarenal H2O loss||–||– | |||
|- | |||
| Nephrology||[[Hypernatremia]]||Renal H2O loss||–||– | |||
|- | |||
| Nephrology||[[Hypernatremia]]||Other||–||– | |||
|- | |||
| Nephrology||[[Hypernatremia]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Polyuria]]||Definition and pathophysiology||Approach to polyuria||– | |||
|- | |||
| Nephrology||[[Polyuria]]||Workup||–||– | |||
|- | |||
| Nephrology||[[Polyuria]]||Osmotic diuresis||–||– | |||
|- | |||
| Nephrology||[[Polyuria]]||Water diuresis||–||– | |||
|- | |||
| Nephrology||[[Polyuria]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Hypokalemia]]||Transcellular shifts||Approach to hypokalemia||– | |||
|- | |||
| Nephrology||[[Hypokalemia]]||GI potassium losses||–||– | |||
|- | |||
| Nephrology||[[Hypokalemia]]||Renal potassium losses||–||– | |||
|- | |||
| Nephrology||[[Hypokalemia]]||Clinical manifestations||–||– | |||
|- | |||
| Nephrology||[[Hypokalemia]]||Workup||–||– | |||
|- | |||
| Nephrology||[[Hypokalemia]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Hyperkalemia]]||Transcellular shifts||–||– | |||
|- | |||
| Nephrology||[[Hyperkalemia]]||Decreased GFR||–||– | |||
|- | |||
| Nephrology||[[Hyperkalemia]]||Normal GFR but with Ø renal K excretion||–||– | |||
|- | |||
| Nephrology||[[Hyperkalemia]]||Clinical manifestations||–||– | |||
|- | |||
| Nephrology||[[Hyperkalemia]]||Workup||–||Treatment of Hyperkalemia | |||
|- | |||
| Nephrology||[[Acute kidney injury]]||Definition||–||– | |||
|- | |||
| Nephrology||[[Acute kidney injury]]||Workup||–||Etiologies and Diagnosis of Acute Kidney Injury | |||
|- | |||
| Nephrology||[[Acute kidney injury]]||Contrast-induced acute kidney injury (CIAKI)||–||– | |||
|- | |||
| Nephrology||[[Acute kidney injury]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Chronic kidney disease]]||Definition and etiologies||–||Stages of CKD | |||
|- | |||
| Nephrology||[[Chronic kidney disease]]||Treatment||–||Signs and Symptoms of Uremia | |||
|- | |||
| Nephrology||[[Diuresis]]||General considerations||–||Approach to Diuresis | |||
|- | |||
| Nephrology||[[Diuresis]]||Loop diuretics||–||– | |||
|- | |||
| Nephrology||[[Diuresis]]||Thiazide diuretics||–||– | |||
|- | |||
| Nephrology||[[Diuresis]]||K-sparing diuretics||–||– | |||
|- | |||
| Nephrology||[[Diuresis]]||Disease state specific regimens||–||– | |||
|- | |||
| Nephrology||[[Diuresis]]||Adverse effects||–||– | |||
|- | |||
| Nephrology||[[Renal replacement and dialysis]]||General||–||– | |||
|- | |||
| Nephrology||[[Renal replacement and dialysis]]||Hemodialysis (HD)||–||– | |||
|- | |||
| Nephrology||[[Renal replacement and dialysis]]||Continuous veno-venous hemofiltration (CVVH)||–||– | |||
|- | |||
| Nephrology||[[Renal replacement and dialysis]]||Peritoneal dialysis (PD)||–||– | |||
|- | |||
| Nephrology||[[Renal replacement and dialysis]]||Kidney transplantation||–||– | |||
|- | |||
| Nephrology||[[Glomerulonephritis]]||Definition||Approach to glomerulonephritis||– | |||
|- | |||
| Nephrology||[[Glomerulonephritis]]||ANCA-Positive Vasculitis||–||ANCA-Positive Vasculitis | |||
|- | |||
| Nephrology||[[Glomerulonephritis]]||Anti-GBM Disease||–||Anti-GBM Disease | |||
|- | |||
| Nephrology||[[Glomerulonephritis]]||Immune Complex Disease||–||Immune Complex Disease | |||
|- | |||
| Nephrology||[[Glomerulonephritis]]||Workup||–||– | |||
|- | |||
| Nephrology||[[Glomerulonephritis]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Asymptomatic glomerular hematuria]]||Definition and etiologies||–||– | |||
|- | |||
| Nephrology||[[Asymptomatic glomerular hematuria]]||IgA nephropathy||–||– | |||
|- | |||
| Nephrology||[[Nephrotic syndrome]]||Definition||–||– | |||
|- | |||
| Nephrology||[[Nephrotic syndrome]]||Primary glomerular diseases||–||– | |||
|- | |||
| Nephrology||[[Nephrotic syndrome]]||Systemic diseases||–||– | |||
|- | |||
| Nephrology||[[Nephrotic syndrome]]||Workup||–||– | |||
|- | |||
| Nephrology||[[Nephrotic syndrome]]||Treatment||–||– | |||
|- | |||
| Nephrology||[[Urinalysis]]||Urine Dipstick||–||Urine Dipstick | |||
|- | |||
| Nephrology||[[Urinalysis]]||Urine Sediment||–||Urine Sediment | |||
|- | |||
| Nephrology||[[Proteinuria]]||Proteinuria||–||Etiologies of Proteinuria | |||
|- | |||
| Nephrology||[[Hematuria]]||Workup||–||Etiologies of Hematuria | |||
|- | |||
| Nephrology||[[Nephrolithiasis]]||Types of stones and risk factors||–||– | |||
|- | |||
| Nephrology||[[Nephrolithiasis]]||Clinical manifestations||–||– | |||
|- | |||
| Nephrology||[[Nephrolithiasis]]||Workup||–||– | |||
|- | |||
| Nephrology||[[Nephrolithiasis]]||Acute treatment||–||– | |||
|- | |||
| Nephrology||[[Nephrolithiasis]]||Chronic treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Anemia]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Anemia]]||Diagnostic evaluation||Approach to anemia||– | |||
|- | |||
| Hematology-Oncology||[[Microcytic anemia]]||Approach to microcytic anemias||Approach to microcytic anemias||– | |||
|- | |||
| Hematology-Oncology||[[Microcytic anemia]]||Iron deficiency ||–||– | |||
|- | |||
| Hematology-Oncology||[[Microcytic anemia]]||Thalassemias||–||– | |||
|- | |||
| Hematology-Oncology||[[Microcytic anemia]]||Anemia of chronic inflammation||–||– | |||
|- | |||
| Hematology-Oncology||[[Microcytic anemia]]||Sideroblastic anemia||–||– | |||
|- | |||
| Hematology-Oncology||[[Normocytic anemia]]||Pancytopenia||–||– | |||
|- | |||
| Hematology-Oncology||[[Normocytic anemia]]||Anemia of chronic inflammation||–||– | |||
|- | |||
| Hematology-Oncology||[[Normocytic anemia]]||Anemias of chronic disorders||–||– | |||
|- | |||
| Hematology-Oncology||[[Normocytic anemia]]||Sideroblastic anemia||–||– | |||
|- | |||
| Hematology-Oncology||[[Normocytic anemia]]||Pure red cell aplasia||–||– | |||
|- | |||
| Hematology-Oncology||[[Macrocytic anemia]]||Megaloblastic anemia||–||– | |||
|- | |||
| Hematology-Oncology||[[Macrocytic anemia]]||Folate deficiency||–||– | |||
|- | |||
| Hematology-Oncology||[[Macrocytic anemia]]||Vitamin B12 deficiency||–||– | |||
|- | |||
| Hematology-Oncology||[[Macrocytic anemia]]||Nonmegaloblastic macrocytic anemias||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancytopenia]]||Etiologies||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancytopenia]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancytopenia]]||Aplastic anemia||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancytopenia]]||Myelodysplastic syndromes (MDS)||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancytopenia]]||Paroxysmal nocturnal hemoglobinuria (PNH)||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancytopenia]]||Myelophthisic anemia||–||– | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Diagnostic evaluation||–||Causes of Hemolytic Anemia by Mechanism | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Glucose-6-phosphate dehydrogenase (G6PD) deficiency||–||– | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Sickle cell anemia||–||– | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Hereditary spherocytosis (HS)||–||– | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Autoimmune hemolytic anemia (AIHA)||–||– | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Drug-induced hemolytic anemia||–||– | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Microangiopathic hemolytic anemia (MAHA)||–||– | |||
|- | |||
| Hematology-Oncology||[[Hemolytic anemia]]||Hypersplenism||–||Causes of Splenomegaly | |||
|- | |||
| Hematology-Oncology||[[Disorders of hemostasis]]||Approach to abnormal hemostasis||Approach to abnormal hemostasis||– | |||
|- | |||
| Hematology-Oncology||[[Disorders of hemostasis]]||Clinical Characteristics of Bleeding Disorders||–||Clinical Characteristics of Bleeding Disorders | |||
|- | |||
| Hematology-Oncology||[[Disorders of hemostasis]]||Coagulation Cascade||Coagulation Cascade||– | |||
|- | |||
| Hematology-Oncology||[[Disorders of hemostasis]]||Purpura||–||– | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Etiologies||Approach to thrombocytopenia||– | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Thrombocytopenia and Risk of Bleeding||–||Thrombocytopenia and Risk of Bleeding | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Primary immune thrombocytopenic purpura (ITP)||–||Treatment of Primary ITP in Adults | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Heparin-Induced Thrombocytopenia||–||Overview of Heparin-Induced Thrombocytopenia | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Evaluation of Suspected HIT||–||Evaluation of Suspected HIT | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Hemolytic-uremic syndrome (HUS)||–||– | |||
|- | |||
| Hematology-Oncology||[[Thrombocytopenia]]||Thrombotic thrombocytopenic purpura (TTP)||–||– | |||
|- | |||
| Hematology-Oncology||[[Disorders of platelet function]]||Tests of platelet function||–||Mechanisms and Etiologies of Platelet Function Abnormalities | |||
|- | |||
| Hematology-Oncology||[[Disorders of platelet function]]||von Willebrand’s disease (vWD)||–||– | |||
|- | |||
| Hematology-Oncology||[[Disorders of platelet function]]||Uremic bleeding||–||– | |||
|- | |||
| Hematology-Oncology||[[Coagulopathies]]||Screening Test Abnormalities in Inherited and Acquired Coagulopathies||–||Screening Test Abnormalities in Inherited and Acquired Coagulopathies | |||
|- | |||
| Hematology-Oncology||[[Coagulopathies]]||Further coagulation tests||–||– | |||
|- | |||
| Hematology-Oncology||[[Coagulopathies]]||Hemophilias||–||– | |||
|- | |||
| Hematology-Oncology||[[Coagulopathies]]||Coagulation factor inhibitors||–||– | |||
|- | |||
| Hematology-Oncology||[[Coagulopathies]]||Disseminated intravascular coagulation (DIC)||–||– | |||
|- | |||
| Hematology-Oncology||[[Coagulopathies]]||Vitamin K deficiency||–||Properties and Antidotes for Anticoagulants and Fibrinolytics | |||
|- | |||
| Hematology-Oncology||[[Hypercoagulable states]]||Inherited Hypercoagulable States||–||Inherited Hypercoagulable States | |||
|- | |||
| Hematology-Oncology||[[Hypercoagulable states]]||Vascular Beds Affected by Inherited and Acquired Hypercoagulable States||–||Vascular Beds Affected by Inherited and Acquired Hypercoagulable States | |||
|- | |||
| Hematology-Oncology||[[Hypercoagulable states]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Hypercoagulable states]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Hypercoagulable states]]||Antiphospholipid syndrome (APS)||–||– | |||
|- | |||
| Hematology-Oncology||[[Disorders of leukocytes]]||Neutrophilia||–||Neutrophilia | |||
|- | |||
| Hematology-Oncology||[[Disorders of leukocytes]]||Neutropenia||–||Neutropenia | |||
|- | |||
| Hematology-Oncology||[[Disorders of leukocytes]]||Lymphocytosis||–||Lymphocytosis | |||
|- | |||
| Hematology-Oncology||[[Disorders of leukocytes]]||Monocytosis||–||Monocytosis | |||
|- | |||
| Hematology-Oncology||[[Disorders of leukocytes]]||Eosinophilia||–||Eosinophilia | |||
|- | |||
| Hematology-Oncology||[[Disorders of leukocytes]]||Basophilia||–||Basophilia | |||
|- | |||
| Hematology-Oncology||[[Disorders of leukocytes]]||Lymphadenopathy||–||Lymphadenopathy | |||
|- | |||
| Hematology-Oncology||[[Transfusion therapy]]||Blood Products and Indications||–||Blood Products and Indications | |||
|- | |||
| Hematology-Oncology||[[Transfusion therapy]]||Transfusion Complications||–||Transfusion Complications | |||
|- | |||
| Hematology-Oncology||[[Transfusion therapy]]||Transfusion Reactions||–||Transfusion Reactions | |||
|- | |||
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Myeloid neoplasm overview||–||WHO 2008 Myeloid Neoplasm Categories | |||
|- | |||
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Myelodysplastic syndromes (MDS) overview||–||WHO 2008 Classification Systems for MDS | |||
|- | |||
| Hematology-Oncology||[[Myelodysplastic syndromes]]||Revised International Prognostic Scoring System||–||Revised International Prognostic Scoring System for AML | |||
|- | |||
| Hematology-Oncology||[[Myeloproliferative neoplasms (mpn)]]||Myeloproliferative Neoplasms (MPN)||–||– | |||
|- | |||
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Etiologies of erythrocytosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Polycythemia vera (pv)]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Etiologies of thrombocytosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Essential thrombocythemia (et)]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Etiologies of myelofibrosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Primary myelofibrosis (pmf)]]||Complications and prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute leukemia]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute leukemia]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute leukemia]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute leukemia]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Classification||–||WHO 2008 Classification of AML | |||
|- | |||
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Treatment||–||AML Genetics | |||
|- | |||
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute myelogenous leukemia (aml)]]||Acute Promyelocytic Leukemia (APL)||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Classification||–||WHO Immunophenotype Classification of ALL | |||
|- | |||
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Acute lymphoblastic leukemia (all)]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Treatment||–||Goals of TKI Therapy | |||
|- | |||
| Hematology-Oncology||[[Chronic myelogenous leukemia (cml)]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Diagnostic evaluation||–||CLL Staging | |||
|- | |||
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Chronic lymphocytic leukemia (cll)]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Lymphoma]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Lymphoma]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Lymphoma]]||Diagnostic and staging evaluation||–||Ann Arbor Staging System with Cotswolds Modifications | |||
|- | |||
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Pathology||–||WHO Histologic Classification of Classical HL | |||
|- | |||
| Hematology-Oncology||[[Hodgkin lymphoma (hl)]]||Treatment||–||International Prognostic Score (IPS) | |||
|- | |||
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Epidemiology and risk factors||–||WHO Classification of Lymphoid Malignancies | |||
|- | |||
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||Prognosis||–||Follicular Lymphoma International Prognostic Index (FLIPI) | |||
|- | |||
| Hematology-Oncology||[[Non-hodgkin lymphoma (nhl)]]||HIV-associated NHL||–||International Prognostic Index (IPI) for Aggressive NHL | |||
|- | |||
| Hematology-Oncology||[[Multiple myeloma]]||Definition and epidemiology||–||– | |||
|- | |||
| Hematology-Oncology||[[Multiple myeloma]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Multiple myeloma]]||Diagnostic and staging evaluation||–||Multiple Myeloma Staging Systems | |||
|- | |||
| Hematology-Oncology||[[Multiple myeloma]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Definition and epidemiology||–||– | |||
|- | |||
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Management||–||– | |||
|- | |||
| Hematology-Oncology||[[Monoclonal gammopathy of uncertain significance]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Waldenstrom's macroglobulinemia]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Indications||–||Categories of Stem Cell Transplantation | |||
|- | |||
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Transplantation procedure||–||Prophylaxis and Supportive Medications during HSCT | |||
|- | |||
| Hematology-Oncology||[[Hematopoietic stem cell transplantation]]||Complications||–||Timing of Complications following Allogeneic HSCT | |||
|- | |||
| Hematology-Oncology||[[Lung cancer]]||Pathology and Genetics of Lung Cancer||–||Pathology and Genetics of Lung Cancer | |||
|- | |||
| Hematology-Oncology||[[Lung cancer]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Lung cancer]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Lung cancer]]||Screening||–||– | |||
|- | |||
| Hematology-Oncology||[[Lung cancer]]||Diagnostic and staging evaluation||–||TNM Staging System for NSCLC | |||
|- | |||
| Hematology-Oncology||[[Lung cancer]]||NSCLC Treatment||–||NSCLC Simplified Staging Schema | |||
|- | |||
| Hematology-Oncology||[[Lung cancer]]||SCLC Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Breast cancer]]||Epidemiology and genetics||–||– | |||
|- | |||
| Hematology-Oncology||[[Breast cancer]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Breast cancer]]||Screening||–||– | |||
|- | |||
| Hematology-Oncology||[[Breast cancer]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Breast cancer]]||Staging||–||Simplified Staging System for Breast Cancer | |||
|- | |||
| Hematology-Oncology||[[Breast cancer]]||Treatment||–||Treatment of Carcinoma in situ and Invasive Carcinoma of the Breast | |||
|- | |||
| Hematology-Oncology||[[Breast cancer]]||Prevention||–||– | |||
|- | |||
| Hematology-Oncology||[[Prostate cancer]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Prostate cancer]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Prostate cancer]]||Screening||–||– | |||
|- | |||
| Hematology-Oncology||[[Prostate cancer]]||Diagnostic and staging evaluation||–||TNM Staging and Treatment of Prostate Cancer | |||
|- | |||
| Hematology-Oncology||[[Prostate cancer]]||Prognosis||–||– | |||
|- | |||
| Hematology-Oncology||[[Prostate cancer]]||Prevention||–||– | |||
|- | |||
| Hematology-Oncology||[[Colorectal cancer]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Colorectal cancer]]||Pathology and genetics||–||– | |||
|- | |||
| Hematology-Oncology||[[Colorectal cancer]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Colorectal cancer]]||Screening||–||– | |||
|- | |||
| Hematology-Oncology||[[Colorectal cancer]]||Staging||–||Treatment Based on TNM and Modified Dukes Staging of Colorectal Cancer | |||
|- | |||
| Hematology-Oncology||[[Chemotherapy side effects]]||Chemotherapy Side Effects||–||Select Adverse Effects from Chemotherapy | |||
|- | |||
| Hematology-Oncology||[[Pancreatic tumors]]||Pathology and genetics||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancreatic tumors]]||Epidemiology and risk factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancreatic tumors]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancreatic tumors]]||Diagnostic and staging evaluation||–||Staging and Prognosis of Pancreatic Adenocarcinoma | |||
|- | |||
| Hematology-Oncology||[[Pancreatic tumors]]||Treatment of pancreatic adenocarcinoma||–||– | |||
|- | |||
| Hematology-Oncology||[[Pancreatic tumors]]||Cystic lesions of the pancreas||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Definition||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Pathophysiology and microbiology||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Prevention||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Risk stratification||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Initial antibiotic therapy||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Modification to initial antibiotic regimen||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Duration of therapy||–||– | |||
|- | |||
| Hematology-Oncology||[[Fever and neutropenia]]||Role of hematopoietic growth factors||–||– | |||
|- | |||
| Hematology-Oncology||[[Spinal cord compression]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Spinal cord compression]]||Diagnostic evaluation||–||– | |||
|- | |||
| Hematology-Oncology||[[Spinal cord compression]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Tumor lysis syndrome]]||Clinical manifestations||–||– | |||
|- | |||
| Hematology-Oncology||[[Tumor lysis syndrome]]||Prophylaxis||–||– | |||
|- | |||
| Hematology-Oncology||[[Tumor lysis syndrome]]||Treatment||–||– | |||
|- | |||
| Hematology-Oncology||[[Cancer of unknown primary site]]||Cancer of Unknown Primary Site||–||Evaluation of Cancer of Unknown Primary Site | |||
|- | |||
| Infectious Diseases||[[Pneumonia]]||Microbiology of Pneumonia||–||Microbiology of Pneumonia | |||
|- | |||
| Infectious Diseases||[[Pneumonia]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Pneumonia]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Pneumonia]]||Prognosis||–||– | |||
|- | |||
| Infectious Diseases||[[Pneumonia]]||Treatment||–||Treatment of Pneumonia | |||
|- | |||
| Infectious Diseases||[[Pneumonia]]||Prevention||–||– | |||
|- | |||
| Infectious Diseases||[[Viral respiratory infections]]||Microbiology & epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Viral respiratory infections]]||Diagnosis||–||– | |||
|- | |||
| Infectious Diseases||[[Viral respiratory infections]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Viral respiratory infections]]||Prevention||–||– | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Candida species||–||Treatment of Candidiasis | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Cryptococcus||–||– | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Histoplasmosis||–||– | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Coccidioidomycosis||–||– | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Blastomycosis||–||– | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Aspergillosis||–||– | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Zygomycetes||–||– | |||
|- | |||
| Infectious Diseases||[[Fungal infections]]||Fungal diagnostics||–||– | |||
|- | |||
| Infectious Diseases||[[Infections in immunocompromised hosts]]||Classic Infectious Etiologies in Immunocompromised Hosts||–||Classic Infectious Etiologies in Immunocompromised Hosts | |||
|- | |||
| Infectious Diseases||[[Urinary tract infection]]||Definitions||–||– | |||
|- | |||
| Infectious Diseases||[[Urinary tract infection]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Urinary tract infection]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Urinary tract infection]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Urinary tract infection]]||Treatment||–||Treatment of UTI | |||
|- | |||
| Infectious Diseases||[[Cellulitis]]||Microbiology & clinical||–||– | |||
|- | |||
| Infectious Diseases||[[Cellulitis]]||Diagnosis||–||Microbiology of Bite Infections | |||
|- | |||
| Infectious Diseases||[[Cellulitis]]||Treatment||–||Treatment of Cellulitis | |||
|- | |||
| Infectious Diseases||[[Other cutaneous infections]]||Other Cutaneous Infections||–||Other Cutaneous Infections | |||
|- | |||
| Infectious Diseases||[[Diabetic foot]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Diabetic foot]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Diabetic foot]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Diabetic foot]]||Treatment||–||Treatment of Diabetic Foot | |||
|- | |||
| Infectious Diseases||[[Necrotizing fasciitis]]||Definition||–||– | |||
|- | |||
| Infectious Diseases||[[Necrotizing fasciitis]]||Epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Necrotizing fasciitis]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Necrotizing fasciitis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Necrotizing fasciitis]]||Diagnostic signs||–||– | |||
|- | |||
| Infectious Diseases||[[Necrotizing fasciitis]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Necrotizing fasciitis]]||Prognosis||–||– | |||
|- | |||
| Infectious Diseases||[[Clostridial myonecrosis]]||Definition||–||– | |||
|- | |||
| Infectious Diseases||[[Clostridial myonecrosis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Clostridial myonecrosis]]||Diagnostic signs||–||– | |||
|- | |||
| Infectious Diseases||[[Clostridial myonecrosis]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Osteomyelitis]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Osteomyelitis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Osteomyelitis]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Osteomyelitis]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Epidural abscess]]||Etiology||–||– | |||
|- | |||
| Infectious Diseases||[[Epidural abscess]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Epidural abscess]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Epidural abscess]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Acute bacterial meningitis]]||Definition||–||Microbiology in Adult Meningitis | |||
|- | |||
| Infectious Diseases||[[Acute bacterial meningitis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Acute bacterial meningitis]]||Physical exam||–||– | |||
|- | |||
| Infectious Diseases||[[Acute bacterial meningitis]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Acute bacterial meningitis]]||Recurrent meningitis||–||Typical CSF Findings in Meningitis | |||
|- | |||
| Infectious Diseases||[[Acute bacterial meningitis]]||Treatment||–||Treatment of Meningitis | |||
|- | |||
| Infectious Diseases||[[Acute bacterial meningitis]]||Prognosis||–||– | |||
|- | |||
| Infectious Diseases||[[Aseptic meningitis]]||Definition||–||– | |||
|- | |||
| Infectious Diseases||[[Aseptic meningitis]]||Etiologies||–||– | |||
|- | |||
| Infectious Diseases||[[Aseptic meningitis]]||Empiric treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Encephalitis]]||Definition||–||– | |||
|- | |||
| Infectious Diseases||[[Encephalitis]]||Etiologies||–||– | |||
|- | |||
| Infectious Diseases||[[Encephalitis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Encephalitis]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Encephalitis]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Bell's palsy]]||Definition & etiologies||–||– | |||
|- | |||
| Infectious Diseases||[[Bell's palsy]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Bell's palsy]]||Diagnosis||–||– | |||
|- | |||
| Infectious Diseases||[[Bell's palsy]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Zoster]]||Definition & etiology||–||– | |||
|- | |||
| Infectious Diseases||[[Zoster]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Zoster]]||Diagnosis||–||– | |||
|- | |||
| Infectious Diseases||[[Zoster]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Definition||–||Microbiology of Endocarditis | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Predisposing conditions||–||Modified Duke Criteria for Endocarditis | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Physical exam||–||– | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Indications for surgery||–||– | |||
|- | |||
| Infectious Diseases||[[Bacterial endocarditis]]||Prognosis||–||Endocarditis prophylaxis | |||
|- | |||
| Infectious Diseases||[[Bacteremia]]||Etiologies||–||– | |||
|- | |||
| Infectious Diseases||[[Bacteremia]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Bacteremia]]||Risk factors for true bacteremia ||–||– | |||
|- | |||
| Infectious Diseases||[[Bacteremia]]||Diagnosis||–||– | |||
|- | |||
| Infectious Diseases||[[Bacteremia]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Microbiology & natural history||–||– | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Screening for prior infection||–||– | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Diagnostic studies for active TB||–||– | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Preventive therapy||–||Prophylactic Regimen for TB | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Treatment of active tuberculosis||–||Antituberculous Medications | |||
|- | |||
| Infectious Diseases||[[Tuberculosis]]||Antituberculous Treatment Regimens||–||Antituberculous Treatment Regimens | |||
|- | |||
| Infectious Diseases||[[Hiv/aids]]||Definition||–||– | |||
|- | |||
| Infectious Diseases||[[Hiv/aids]]||Epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Hiv/aids]]||Acute retroviral syndrome||–||– | |||
|- | |||
| Infectious Diseases||[[Hiv/aids]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Hiv/aids]]||Approach to newly diagnosed HIV pt||–||Antiretrovirals and Side Effects | |||
|- | |||
| Infectious Diseases||[[Hiv/aids]]||Approach to previously established HIV pt||–||– | |||
|- | |||
| Infectious Diseases||[[Hiv/aids]]||Opportunistic infection prophylaxis||–||Opportunistic infection prophylaxis | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Fever||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Cutaneous||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Ophthalmologic||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Oral||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Endocrine/metabolic||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Cardiac||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Pulmonary||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Gastrointestinal & hepatobiliary||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Renal||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Hematologic/oncologic||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Neurologic||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Disseminated Mycobacterium avium complex||–||– | |||
|- | |||
| Infectious Diseases||[[Complications of hiv/aids]]||Cytomegalovirus||–||– | |||
|- | |||
| Infectious Diseases||[[Tick-borne illness]]||Distinguishing features of tick-borne illnesses||–||Distinguishing features of tick-borne illnesses | |||
|- | |||
| Infectious Diseases||[[Lyme disease]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Lyme disease]]||Epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Lyme disease]]||Diagnostic studies||–||– | |||
|- | |||
| Infectious Diseases||[[Lyme disease]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Rocky mountain spotted fever]]||Microbiology & epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Rocky mountain spotted fever]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Rocky mountain spotted fever]]||Diagnosis||–||– | |||
|- | |||
| Infectious Diseases||[[Rocky mountain spotted fever]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Diagnosis||–||– | |||
|- | |||
| Infectious Diseases||[[Ehrlichiosis/anaplasmosis]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Babesiosis]]||Microbiology & epidemiology||–||– | |||
|- | |||
| Infectious Diseases||[[Babesiosis]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Babesiosis]]||Diagnosis||–||– | |||
|- | |||
| Infectious Diseases||[[Babesiosis]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Tularemia]]||Microbiology||–||– | |||
|- | |||
| Infectious Diseases||[[Tularemia]]||Clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Tularemia]]||Diagnosis & treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Fever syndromes]]||Diagnosis approach||–||– | |||
|- | |||
| Infectious Diseases||[[Fever of unknown origin]]||Definition & etiologies||–||Etiologies of Classic FUO | |||
|- | |||
| Infectious Diseases||[[Fever of unknown origin]]||Workup||–||– | |||
|- | |||
| Infectious Diseases||[[Fever of unknown origin]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Fever and rash]]||Approach to diagnostic workup||–||Possible Etiology | |||
|- | |||
| Infectious Diseases||[[Fever and rash]]||Treatment||–||– | |||
|- | |||
| Infectious Diseases||[[Fever in a returned traveler]]||Definition & etiologies||–||Common Etiologies of Fever in A Returned Traveler | |||
|- | |||
| Infectious Diseases||[[Fever in a returned traveler]]||Select clinical manifestations||–||– | |||
|- | |||
| Infectious Diseases||[[Fever in a returned traveler]]||Workup||–||– | |||
|- | |||
| Endocrinology||[[Hypopituitary syndromes]]||Panhypopituitarism||–||– | |||
|- | |||
| Endocrinology||[[Hyperpituitary syndromes]]||Pituitary tumors||–||– | |||
|- | |||
| Endocrinology||[[Hyperpituitary syndromes]]||Hyperprolactinemia||–||– | |||
|- | |||
| Endocrinology||[[Hyperpituitary syndromes]]||Acromegaly||–||– | |||
|- | |||
| Endocrinology||[[Hyperpituitary syndromes]]||Cushing's disease||–||– | |||
|- | |||
| Endocrinology||[[Hyperpituitary syndromes]]||Central hyperthyroidism||–||– | |||
|- | |||
| Endocrinology||[[Hyperpituitary syndromes]]||Multiple Endocrine Neoplasia Syndromes||–||Multiple Endocrine Neoplasia Syndromes | |||
|- | |||
| Endocrinology||[[Hyperpituitary syndromes]]||Polyglandular Autoimmune Syndromes||–||Polyglandular Autoimmune Syndromes | |||
|- | |||
| Endocrinology||[[Thyroid disorders]]||Diagnostic Studies in Thyroid Disorders||–||Diagnostic Studies in Thyroid Disorders | |||
|- | |||
| Endocrinology||[[Thyroid disorders]]||Approach to Thyroid Disorders||Approach to Thyroid Disorders||– | |||
|- | |||
| Endocrinology||[[Hypothyroidism]]||Etiologies||–||– | |||
|- | |||
| Endocrinology||[[Hypothyroidism]]||Hashimoto's thyroiditis||–||– | |||
|- | |||
| Endocrinology||[[Hypothyroidism]]||Clinical manifestations||–||– | |||
|- | |||
| Endocrinology||[[Hypothyroidism]]||Diagnostic studies||–||– | |||
|- | |||
| Endocrinology||[[Hypothyroidism]]||Treatment of overt hypothyroidism||–||– | |||
|- | |||
| Endocrinology||[[Hypothyroidism]]||Subclinical hypothyroidism||–||– | |||
|- | |||
| Endocrinology||[[Hyperthyroidism]]||Etiologies||–||– | |||
|- | |||
| Endocrinology||[[Hyperthyroidism]]||Clinical manifestations of hyperthyroidism||–||– | |||
|- | |||
| Endocrinology||[[Hyperthyroidism]]||Laboratory testing||–||– | |||
|- | |||
| Endocrinology||[[Hyperthyroidism]]||Graves' disease||–||– | |||
|- | |||
| Endocrinology||[[Hyperthyroidism]]||Thyroiditis||–||– | |||
|- | |||
| Endocrinology||[[Hyperthyroidism]]||Treatment||–||– | |||
|- | |||
| Endocrinology||[[Hyperthyroidism]]||Subclinical hyperthyroidism||–||– | |||
|- | |||
| Endocrinology||[[Nonthyroidal illness]]||Sick euthyroid syndrome||–||– | |||
|- | |||
| Endocrinology||[[Amiodarone and thyroid disease]]||Amiodarone-induced hypothyroidism||–||– | |||
|- | |||
| Endocrinology||[[Amiodarone and thyroid disease]]||Amiodarone-induced hyperthyroidism||–||– | |||
|- | |||
| Endocrinology||[[Thyroid nodules]]||Approach to thyroid nodules||Approach to thyroid nodules||– | |||
|- | |||
| Endocrinology||[[Cushing's syndrome]]||Definitions||–||– | |||
|- | |||
| Endocrinology||[[Cushing's syndrome]]||Etiologies of hypercortisolism||–||– | |||
|- | |||
| Endocrinology||[[Cushing's syndrome]]||Clinical manifestations||Approach to suspected Cushing's syndrome||– | |||
|- | |||
| Endocrinology||[[Cushing's syndrome]]||Treatment of Cushing's syndrome||–||– | |||
|- | |||
| Endocrinology||[[Hyperaldosteronism]]||Etiologies||–||– | |||
|- | |||
| Endocrinology||[[Hyperaldosteronism]]||Clinical manifestations||–||– | |||
|- | |||
| Endocrinology||[[Hyperaldosteronism]]||Diagnostic studies||Approach to suspected hyperaldosteronism||– | |||
|- | |||
| Endocrinology||[[Hyperaldosteronism]]||Treatment||–||– | |||
|- | |||
| Endocrinology||[[Adrenal insufficiency]]||Etiologies||–||– | |||
|- | |||
| Endocrinology||[[Adrenal insufficiency]]||Clinical manfiestations||–||– | |||
|- | |||
| Endocrinology||[[Adrenal insufficiency]]||Diagnostic studies||–||– | |||
|- | |||
| Endocrinology||[[Adrenal insufficiency]]||Adrenal insufficiency & critical illness||–||– | |||
|- | |||
| Endocrinology||[[Adrenal insufficiency]]||Treatment||–||– | |||
|- | |||
| Endocrinology||[[Pheochromocytoma]]||Clinical manifestations||–||– | |||
|- | |||
| Endocrinology||[[Pheochromocytoma]]||Diagnostic studies||–||– | |||
|- | |||
| Endocrinology||[[Pheochromocytoma]]||Treatment||–||– | |||
|- | |||
| Endocrinology||[[Adrenal incidentalomas]]||Epidemiology||–||– | |||
|- | |||
| Endocrinology||[[Adrenal incidentalomas]]||Differential diagnosis||–||– | |||
|- | |||
| Endocrinology||[[Adrenal incidentalomas]]||Workup||–||– | |||
|- | |||
| Endocrinology||[[Calcium disorders]]||Pitfalls in measuring calcium||–||Laboratory Findings in Calcium Disorders | |||
|- | |||
| Endocrinology||[[Hypercalcemia]]||Clinical manifestations||–||Etiologies of Hypercalcemia | |||
|- | |||
| Endocrinology||[[Hypercalcemia]]||Diagnostic studies||–||– | |||
|- | |||
| Endocrinology||[[Hypercalcemia]]||Treatment||–||Treatment of Hypercalcemia | |||
|- | |||
| Endocrinology||[[Hypercalcemia]]||Treatment of asymptomatic primary HPT||–||– | |||
|- | |||
| Endocrinology||[[Hypocalcemia]]||Clinical manifestations||–||Etiologies of Hypocalcemia | |||
|- | |||
| Endocrinology||[[Hypocalcemia]]||Diagnostic studies||–||– | |||
|- | |||
| Endocrinology||[[Hypocalcemia]]||Treatment||–||– | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Definition||–||– | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Categories||–||– | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Clinical manifestations||–||– | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Treatment||–||Diabetes Treatment Options | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Insulin Preparations||–||Insulin Preparations | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Complications||–||– | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Outpatient screening and treatment goals||–||– | |||
|- | |||
| Endocrinology||[[Diabetes mellitus]]||Management of hyperglycemia in inpatients||–||– | |||
|- | |||
| Endocrinology||[[Diabetic ketoacidosis]]||Precipitants||–||– | |||
|- | |||
| Endocrinology||[[Diabetic ketoacidosis]]||Pathophysiology||–||– | |||
|- | |||
| Endocrinology||[[Diabetic ketoacidosis]]||Clinical manifestations||–||– | |||
|- | |||
| Endocrinology||[[Diabetic ketoacidosis]]||Diagnostic studies||–||Typical DKA Flow Sheet Setup | |||
|- | |||
| Endocrinology||[[Diabetic ketoacidosis]]||Treatment||–||Treatment of DKA | |||
|- | |||
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Definition, precipitants, pathophysiology||–||– | |||
|- | |||
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Clinical manifestations & dx studies||–||– | |||
|- | |||
| Endocrinology||[[Hyperosmolar hyperglycemic state]]||Treatment||–||– | |||
|- | |||
| Endocrinology||[[Hypoglycemia]]||Clinical manifestations||–||– | |||
|- | |||
| Endocrinology||[[Hypoglycemia]]||Etiologies in diabetics||–||– | |||
|- | |||
| Endocrinology||[[Hypoglycemia]]||Etiologies in nondiabetics||–||– | |||
|- | |||
| Endocrinology||[[Hypoglycemia]]||Evaluation in nondiabetics||–||– | |||
|- | |||
| Endocrinology||[[Hypoglycemia]]||Treatment||–||– | |||
|- | |||
| Endocrinology||[[Lipid disorders]]||Measurements||–||– | |||
|- | |||
| Endocrinology||[[Lipid disorders]]||Primary dyslipidemia||–||– | |||
|- | |||
| Endocrinology||[[Lipid disorders]]||Secondary dyslipidemia||–||Secondary dyslipidemia | |||
|- | |||
| Endocrinology||[[Lipid disorders]]||Physical exam findings||–||– | |||
|- | |||
| Endocrinology||[[Lipid disorders]]||Treatment||–||NCEP Guidelines of Dyslipidemia | |||
|- | |||
| Endocrinology||[[Lipid disorders]]||Drug treatment||–||Drug Treatment of Dyslipidemia | |||
|- | |||
| Rheumatology||[[Arthritis]]||Approach to patients with joint pain||–||Key Physical Exam Findings in Joint Pain | |||
|- | |||
| Rheumatology||[[Arthritis]]||Approach to arthritis||Approach to arthritis||– | |||
|- | |||
| Rheumatology||[[Arthritis]]||Analysis of joint fluid||–||Analysis of Joint Fluid | |||
|- | |||
| Rheumatology||[[Arthritis]]||Comparison of major arthritides||–||Comparison of Major Arthritides | |||
|- | |||
| Rheumatology||[[Arthritis]]||Radiologic features||–||– | |||
|- | |||
| Rheumatology||[[Inflammatory markers & autoantibody testing]]||Inflammatory Markers||–||– | |||
|- | |||
| Rheumatology||[[Inflammatory markers & autoantibody testing]]||Autoantibody Testing||–||– | |||
|- | |||
| Rheumatology||[[Rheumatoid arthritis]]||Definition & epidemiology||–||– | |||
|- | |||
| Rheumatology||[[Rheumatoid arthritis]]||Clinical manifestations||–||Extra-Articular Manifestations of RA | |||
|- | |||
| Rheumatology||[[Rheumatoid arthritis]]||Laboratory & radiologic studies||–||– | |||
|- | |||
| Rheumatology||[[Rheumatoid arthritis]]||ACR/EULAR classification criteria of RA||–||ACR/EULAR classification criteria of RA | |||
|- | |||
| Rheumatology||[[Rheumatoid arthritis]]||Management||–||RA Therapeutics | |||
|- | |||
| Rheumatology||[[Adult onset still’s disease & relapsing polychondritis]]||Adult Onset Still’s Disease||–||– | |||
|- | |||
| Rheumatology||[[Adult onset still’s disease & relapsing polychondritis]]||Relapsing Polychondritis||–||– | |||
|- | |||
| Rheumatology||[[Gout]]||Definition & epidemiology||–||– | |||
|- | |||
| Rheumatology||[[Gout]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Gout]]||Diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Gout]]||Acute treatment||–||Acute Treatment of Gout | |||
|- | |||
| Rheumatology||[[Gout]]||Chronic treatment||–||Urate Lowering Therapy | |||
|- | |||
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Definition||–||– | |||
|- | |||
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Etiologies||–||– | |||
|- | |||
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Calcium pyrophosphate dihydrate deposition disease]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Seronegative spondyloarthritis]]||Classification system||–||– | |||
|- | |||
| Rheumatology||[[Seronegative spondyloarthritis]]||Epidemiology & pathogenesis||–||SpA Epidemiology and Features | |||
|- | |||
| Rheumatology||[[Seronegative spondyloarthritis]]||Major clinical manifestations||–||SpA Distinguishing Features | |||
|- | |||
| Rheumatology||[[Seronegative spondyloarthritis]]||Descriptions of skin manifestations||–||– | |||
|- | |||
| Rheumatology||[[Seronegative spondyloarthritis]]||Clinical assessment||–||– | |||
|- | |||
| Rheumatology||[[Seronegative spondyloarthritis]]||Treatment approach||–||– | |||
|- | |||
| Rheumatology||[[Infectious arthritis]]||Etiologies||–||– | |||
|- | |||
| Rheumatology||[[Infectious arthritis]]||Diagnosis||–||– | |||
|- | |||
| Rheumatology||[[Bacterial arthritis]]||Epidemiology & risk factors||–||– | |||
|- | |||
| Rheumatology||[[Bacterial arthritis]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Bacterial arthritis]]||Additional diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Bacterial arthritis]]||Treatment||–||Treatment of Bacterial Arthritis | |||
|- | |||
| Rheumatology||[[Bacterial arthritis]]||Prosthetic joint infections||–||– | |||
|- | |||
| Rheumatology||[[Disseminated gonococcal infection]]||Epidemiology||–||– | |||
|- | |||
| Rheumatology||[[Disseminated gonococcal infection]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Disseminated gonococcal infection]]||Additional diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Disseminated gonococcal infection]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Epidemiology & risk factors||–||– | |||
|- | |||
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Diagnosis||–||– | |||
|- | |||
| Rheumatology||[[Olecranon and prepatellar bursitis]]||Initial therapy||–||– | |||
|- | |||
| Rheumatology||[[Connective tissue diseases]]||Autoantibodies in Patients with Rheumatic Diseases||–||Autoantibodies in Patients with Rheumatic Diseases | |||
|- | |||
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Definition & epidemiology||–||– | |||
|- | |||
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Classification criteria||–||– | |||
|- | |||
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Diagnostic studies & monitoring||–||Clinical Manifestations of Systemic Sclerosis | |||
|- | |||
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Systemic Sclerosis Subgroup Comparison||–||SSc Subgroup Comparison | |||
|- | |||
| Rheumatology||[[Systemic sclerosis and scleroderma]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Inflammatory myopathies]]||Definition & epidemiology||–||– | |||
|- | |||
| Rheumatology||[[Inflammatory myopathies]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Inflammatory myopathies]]||Diagnostic studies||–||Differential Diagnosis of Myositides, Myopathies, and Myalgias | |||
|- | |||
| Rheumatology||[[Inflammatory myopathies]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Sjogren's syndrome]]||Definition & epidemiology||–||– | |||
|- | |||
| Rheumatology||[[Sjogren's syndrome]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Sjogren's syndrome]]||Diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Sjogren's syndrome]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Mixed connective tissue disease]]||Definition||–||– | |||
|- | |||
| Rheumatology||[[Mixed connective tissue disease]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Mixed connective tissue disease]]||Diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Mixed connective tissue disease]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Raynaud's phenomenon]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Raynaud's phenomenon]]||Primary Raynaud's phenomenon||–||– | |||
|- | |||
| Rheumatology||[[Raynaud's phenomenon]]||Secondary Raynaud's phenomenon||–||– | |||
|- | |||
| Rheumatology||[[Raynaud's phenomenon]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Systemic lupus erythematosus]]||Epidemiology||–||Classification Criteria and Clinical Manifestations of SLE | |||
|- | |||
| Rheumatology||[[Systemic lupus erythematosus]]||Workup||–||Autoantibodies in SLE | |||
|- | |||
| Rheumatology||[[Systemic lupus erythematosus]]||Treatment||–||Treatment of SLE | |||
|- | |||
| Rheumatology||[[Systemic lupus erythematosus]]||Lupus nephritis||–||Lupus nephritis | |||
|- | |||
| Rheumatology||[[Systemic lupus erythematosus]]||Prognosis||–||– | |||
|- | |||
| Rheumatology||[[Systemic lupus erythematosus]]||Drug-induced lupus||–||– | |||
|- | |||
| Rheumatology||[[Vasculitis]]||Distinguishing Characteristics of Vasculitis Subtypes||–||Distinguishing Characteristics of Vasculitis Subtypes | |||
|- | |||
| Rheumatology||[[Large-vessel vasculitis]]||Takayasu's arteritis||–||– | |||
|- | |||
| Rheumatology||[[Large-vessel vasculitis]]||Giant cell arteritis||–||– | |||
|- | |||
| Rheumatology||[[Medium-vessel vasculitis]]||Polyarteritis nodosa||–||– | |||
|- | |||
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Differential Diagnosis of ANCA||–||Differential Diagnosis of ANCA | |||
|- | |||
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Granulomatosis with polyangiitis||–||– | |||
|- | |||
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Microscopic polyangiitis||–||– | |||
|- | |||
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Eosinophilic granulomatosis with polyangiitis||–||– | |||
|- | |||
| Rheumatology||[[Anca-associated small-vessel vasculitis]]||Renal-limited vasculitis||–||– | |||
|- | |||
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Henoch-Schonlein purpura||–||– | |||
|- | |||
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Cryoglobulinemic vasculitis||–||– | |||
|- | |||
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Connective tissue disease-associated vasculitis||–||– | |||
|- | |||
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Cutaneous leukocytoclastic angiitis||–||– | |||
|- | |||
| Rheumatology||[[Immune complex-associated small-vessel vasculitis]]||Behcet's syndrome||–||– | |||
|- | |||
| Rheumatology||[[Igg4-related disease]]||Definition & etiology||–||– | |||
|- | |||
| Rheumatology||[[Igg4-related disease]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Igg4-related disease]]||Diagnosis||–||– | |||
|- | |||
| Rheumatology||[[Igg4-related disease]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Cryoglobulinemia]]||Definition & types||–||– | |||
|- | |||
| Rheumatology||[[Cryoglobulinemia]]||Etiologies||–||– | |||
|- | |||
| Rheumatology||[[Cryoglobulinemia]]||Pathophysiology||–||– | |||
|- | |||
| Rheumatology||[[Cryoglobulinemia]]||Clinical manifestations||–||– | |||
|- | |||
| Rheumatology||[[Cryoglobulinemia]]||Diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Cryoglobulinemia]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Amyloidosis]]||Classification||–||Classification of Amyloidosis | |||
|- | |||
| Rheumatology||[[Amyloidosis]]||Clinical manifestations||–||Clinical Manifestations of Amyloidosis | |||
|- | |||
| Rheumatology||[[Amyloidosis]]||Diagnostic studies||–||– | |||
|- | |||
| Rheumatology||[[Amyloidosis]]||Treatment||–||– | |||
|- | |||
| Rheumatology||[[Amyloidosis]]||Prognosis||–||– | |||
|- | |||
| Neurology||[[Change in mental status]]||Definitions||–||– | |||
|- | |||
| Neurology||[[Change in mental status]]||Initial evaluation||–||Etiologies of Altered Mental Status | |||
|- | |||
| Neurology||[[Change in mental status]]||Neuro Exam of Altered Mental Status||–||Neuro Exam of Altered Mental Status | |||
|- | |||
| Neurology||[[Change in mental status]]||Glasgow Coma Scale||–||Glasgow Coma Scale | |||
|- | |||
| Neurology||[[Change in mental status]]||Initial treatment||–||– | |||
|- | |||
| Neurology||[[Change in mental status]]||Diagnostic studies||–||– | |||
|- | |||
| Neurology||[[Change in mental status]]||Further treatment of delirium||–||– | |||
|- | |||
| Neurology||[[Anoxic brain injury]]||Prevalence||–||– | |||
|- | |||
| Neurology||[[Anoxic brain injury]]||Initial evaluation||–||– | |||
|- | |||
| Neurology||[[Anoxic brain injury]]||Induced hypothermia||–||– | |||
|- | |||
| Neurology||[[Anoxic brain injury]]||Ongoing evaluation||–||– | |||
|- | |||
| Neurology||[[Anoxic brain injury]]||Prognosis||–||– | |||
|- | |||
| Neurology||[[Seizures]]||Definitions||–||– | |||
|- | |||
| Neurology||[[Seizures]]||Differential diagnosis||–||Seizure vs Syncope | |||
|- | |||
| Neurology||[[Seizures]]||Etiologies||–||– | |||
|- | |||
| Neurology||[[Seizures]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Seizures]]||Clinical evaluation||–||– | |||
|- | |||
| Neurology||[[Seizures]]||Diagnostic studies||–||– | |||
|- | |||
| Neurology||[[Seizures]]||Treatment||–||Antiepileptic Drugs and Side Effects | |||
|- | |||
| Neurology||[[Seizures]]||Status epilepticus||–||Treatment of Status Epilepticus | |||
|- | |||
| Neurology||[[Alcohol withdrawal]]||Pathophysiology||–||– | |||
|- | |||
| Neurology||[[Alcohol withdrawal]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Alcohol withdrawal]]||Clinical Institute Withdrawal Assessment scale for Alcohol||–||CIWA-Ar Scale | |||
|- | |||
| Neurology||[[Alcohol withdrawal]]||Treatment||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Etiologies||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Clinical manifestations||–||Stroke Syndromes by Vascular Territory | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Transient ischemic attack||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Physical exam||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Acute workup||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Workup to assess for etiology/modifiable risk factors||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Acute treatment of ischemic stroke||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Secondary stroke prevention||–||– | |||
|- | |||
| Neurology||[[Ischemic stroke]]||Patent foramen ovale||–||– | |||
|- | |||
| Neurology||[[Intracranial hemorrhage]]||Classification by location||–||– | |||
|- | |||
| Neurology||[[Intracranial hemorrhage]]||Etiologies||–||– | |||
|- | |||
| Neurology||[[Intracranial hemorrhage]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Intracranial hemorrhage]]||Workup||–||– | |||
|- | |||
| Neurology||[[Intracranial hemorrhage]]||Management||–||– | |||
|- | |||
| Neurology||[[Weakness & neuromuscular dysfunction]]||Weakness & Neuromuscular Dysfunction||–||Weakness & Neuromuscular Dysfunction | |||
|- | |||
| Neurology||[[Peripheral neuropathies]]||Etiologies||–||– | |||
|- | |||
| Neurology||[[Peripheral neuropathies]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Peripheral neuropathies]]||Diagnostic studies||–||– | |||
|- | |||
| Neurology||[[Peripheral neuropathies]]||Treatment of neuropathic pain||–||– | |||
|- | |||
| Neurology||[[Guillain-barre syndrome]]||Definition & epidemiology||–||– | |||
|- | |||
| Neurology||[[Guillain-barre syndrome]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Guillain-barre syndrome]]||Diagnostic studies||–||– | |||
|- | |||
| Neurology||[[Guillain-barre syndrome]]||Treatment||–||– | |||
|- | |||
| Neurology||[[Myasthenia gravis]]||Definition & epidemiology||–||– | |||
|- | |||
| Neurology||[[Myasthenia gravis]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Myasthenia gravis]]||Diagnostic studies||–||– | |||
|- | |||
| Neurology||[[Myasthenia gravis]]||Treatment||–||– | |||
|- | |||
| Neurology||[[Myopathies]]||Definition & epidemiology||–||– | |||
|- | |||
| Neurology||[[Myopathies]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Myopathies]]||Diagnostic studies||–||– | |||
|- | |||
| Neurology||[[Headache]]||Primary headache syndromes||–||– | |||
|- | |||
| Neurology||[[Headache]]||Secondary causes of headache||–||– | |||
|- | |||
| Neurology||[[Headache]]||Clinical evaluation||–||– | |||
|- | |||
| Neurology||[[Migraine]]||Epidemiology||–||– | |||
|- | |||
| Neurology||[[Migraine]]||Definition & clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Migraine]]||Treatment||–||– | |||
|- | |||
| Neurology||[[Back and spinal cord disease]]||Differential diagnosis of back pain||–||– | |||
|- | |||
| Neurology||[[Back and spinal cord disease]]||Initial evaluation||–||– | |||
|- | |||
| Neurology||[[Spinal cord compression]]||Clinical manifestations||–||– | |||
|- | |||
| Neurology||[[Spinal cord compression]]||Evaluation & treatment||–||Conus Medullaris vs Cauda Equina Syndromes | |||
|- | |||
| Neurology||[[Nerve root compression]]||Clinical manifestations||–||Cervical and Lumbar Radiculopathy | |||
|- | |||
| Neurology||[[Nerve root compression]]||Neurogenic vs Vascular Claudication||–||Neurogenic vs Vascular Claudication | |||
|- | |||
| Neurology||[[Nerve root compression]]||Treatment of nerve root compression||–||– | |||
|- | |||
| Surgical Issues||[[Abdominal pain]]||Viscera and Area to which pain referred||–||Viscera and Area to which pain referred | |||
|- | |||
| Surgical Issues||[[Abdominal pain]]||Etiologies of Abdominal Pain by Location||Etiologies of Abdominal Pain by Location||– | |||
|- | |||
| Surgical Issues||[[Abdominal pain]]||Inital evaluation||–||– | |||
|- | |||
| Surgical Issues||[[Acute abdomen]]||Definition||–||– | |||
|- | |||
| Surgical Issues||[[Acute abdomen]]||Etiologies||–||– | |||
|- | |||
| Surgical Issues||[[Acute abdomen]]||Inital evaluation||–||– | |||
|- | |||
| Surgical Issues||[[Acute abdomen]]||Initial management||–||– | |||
|- | |||
| Surgical Issues||[[Extremity emergencies]]||Acute limb ischemia||–||– | |||
|- | |||
| Surgical Issues||[[Extremity emergencies]]||Compartment syndrome||–||– | |||
|- | |||
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Tracheostomy||–||– | |||
|- | |||
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Chest tubes||–||– | |||
|- | |||
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Gastrostomy/jejunostomy tubes||–||– | |||
|- | |||
| Surgical Issues||[[Surgical tubes, drains, and wounds]]||Suture/staple removal||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Vaginal bleeding]]||Etiologies||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Vaginal bleeding]]||History & exam||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Vaginal bleeding]]||Laboratory evaluation & imaging||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Vaginal discharge]]||Etiologies||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Vaginal discharge]]||Initial evaluation||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Vaginal discharge]]||Treatment||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Adnexal mass in non-pregnant woman]]||Etiologies||–||– | |||
|- | |||
| Ob/Gyn Issues||[[Adnexal mass in non-pregnant woman]]||Initial evaluation||–||– | |||
|- | |||
| Ophthalmic Issues||[[Acute visual changes]]||Etiologies of Acute Vision Loss||–||Etiologies of Acute Vision Loss | |||
|- | |||
| Ophthalmic Issues||[[Acute visual changes]]||Descriptions & etiologies of other visual changes||–||– | |||
|- | |||
| Ophthalmic Issues||[[Red eye]]||Common Etiologies of Red Eye||–||Common Etiologies of Red Eye | |||
|- | |||
| Ophthalmic Issues||[[Other conditions]]||Optic Nerve Disorders||–||– | |||
|- | |||
| Ophthalmic Issues||[[Other conditions]]||Ocular motor palsies||–||– | |||
|- | |||
| Ophthalmic Issues||[[Initial evaluation]]||Initial evaluation||–||– | |||
|- | |||
| ICU Medications||[[Icu medications]]||ICU Medications||–||ICU Medications | |||
|- | |||
| ACLS||[[Pulmonary edema, hypotension or shock]]||ACLS pulmonary edema, hypotension or shock algorithm||ACLS pulmonary edema, hypotension or shock algorithm||– | |||
|- | |||
| ACLS||[[Tachycardia]]||ACLS tachycardia algorithm||ACLS tachycardia algorithm||– | |||
|- | |||
| ACLS||[[Bradycardia]]||ACLS bradycardia algorithm||ACLS bradycardia algorithm||– | |||
|- | |||
| ACLS||[[Vf/pulseless vt, asystole, & pea]]||ACLS VF/Pulseless VT, asystole, & PEA algorithm||ACLS VF/Pulseless VT, asystole, & PEA algorithm||– | |||
|- | |||
| Quick References||[[Chest imaging patterns]]||Chest Imaging Patterns||–||Chest Imaging Patterns | |||
|- | |||
| Quick References||[[Peripheral smear findings]]||Peripheral Smear Findings||–||Peripheral Smear Findings | |||
|- | |||
| Quick References||[[Heparin for thromboembolism]]||Heparin for Thromboembolism||–||Heparin for Thromboembolism | |||
|- | |||
| Quick References||[[Heparin for acs]]||Heparin for ACS||–||Heparin for ACS | |||
|- | |||
| Quick References||[[Warfarin loading nomogram]]||Warfarin Loading Nomogram||–||Warfarin Loading Nomogram | |||
|- | |||
| Quick References||[[Warfarin-heparin overlap therapy]]||Warfarin-Heparin Overlap Therapy||–||Common Warfarin-Drug Interactions | |||
|} |
Latest revision as of 14:51, 10 November 2016
Specialty | Topic | Section | Figure | Table |
---|---|---|---|---|
Cardiology | Electrocardiography | Approach | QRS axis | – |
Cardiology | Electrocardiography | Left axis deviation (LAD) | – | – |
Cardiology | Electrocardiography | Right axis deviation (RAD) | – | Bunble branch blocks |
Cardiology | Electrocardiography | Prolonged QT interval | ECG P Wave Criteria | – |
Cardiology | Electrocardiography | Left ventricular hypertrophy (LVH) | – | – |
Cardiology | Electrocardiography | Right ventricular hypertrophy (RVH) | – | – |
Cardiology | Electrocardiography | Ddx of dominant R wave in V1 or V2 | – | – |
Cardiology | Electrocardiography | Poor R wave progression (PRWP) | – | – |
Cardiology | Electrocardiography | Pathologic Q waves | – | – |
Cardiology | Electrocardiography | ST elevation (STE) | – | – |
Cardiology | Electrocardiography | ST depression (STD) | – | – |
Cardiology | Electrocardiography | T wave inversion (TWI) | – | – |
Cardiology | Electrocardiography | Low voltage | – | – |
Cardiology | Chest pain | Causes of Chest Pain | – | Causes of Chest Pain |
Cardiology | Chest pain | Initial approach | – | – |
Cardiology | Noninvasive evaluation of cad | Noninvasive Evaluation of CAD | – | Noninvasive Evaluation of CAD |
Cardiology | Noninvasive evaluation of cad | Stress testing | – | – |
Cardiology | Noninvasive evaluation of cad | Test results | – | – |
Cardiology | Noninvasive evaluation of cad | High-risk test results | – | – |
Cardiology | Noninvasive evaluation of cad | Myocardial viability | – | – |
Cardiology | Noninvasive evaluation of cad | CT & MR coronary angio | – | – |
Cardiology | Noninvasive evaluation of cad | Coronary artery calcium score | – | – |
Cardiology | Coronary angiography and revascularization | Indications for coronary angiography in stable CAD or asx Pts | – | – |
Cardiology | Coronary angiography and revascularization | Precath checklist | – | – |
Cardiology | Coronary angiography and revascularization | Coronary revascularization in stable CAD | – | – |
Cardiology | Coronary angiography and revascularization | PCI | – | – |
Cardiology | Coronary angiography and revascularization | Post-PCI complications | – | – |
Cardiology | Acute coronary syndromes | Ddx (causes of myocardial ischemia/infarction other than atherosclerotic plaque rupture) | – | Spectrum of Acute Coronary Syndromes |
Cardiology | Acute coronary syndromes | Clinical manifestations | – | – |
Cardiology | Acute coronary syndromes | Physical exam | – | – |
Cardiology | Acute coronary syndromes | Diagnostic studies | – | Localization of MI |
Cardiology | Acute coronary syndromes | Prinzmetal’s (variant) angina | – | – |
Cardiology | Acute coronary syndromes | Approach to triage | – | Likelihood of ACS |
Cardiology | Acute coronary syndromes | Coronary angiography | – | – |
Cardiology | Ua/nstemi | Approach to UA/NSTEMI | Approach to UA/NSTEMI | – |
Cardiology | Ua/nstemi | TIMI Risk Score for UA/NSTEMI | – | TIMI Risk Score for UA/NSTEMI |
Cardiology | Ua/nstemi | Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI | – | Anti-Ischemic and Antiplatelet Therapy for UA/NSTEMI |
Cardiology | Ua/nstemi | Anticoagulant Therapy for UA/NSTEMI | – | Anticoagulant Therapy for UA/NSTEMI |
Cardiology | Stemi | Requisite STE (at J point) | – | – |
Cardiology | Stemi | Reperfusion (“time is muscle”) | – | Fibrinolysis vs Hospital Transfer for Primary PCI |
Cardiology | Stemi | Primary PCI | – | – |
Cardiology | Stemi | Fibrinolysis | – | Contraindications to Fibrinolysis |
Cardiology | Stemi | Non-primary PCI | – | – |
Cardiology | Stemi | Antiplatelet Therapy for STEMI | – | Antiplatelet Therapy for STEMI |
Cardiology | Stemi | Anticoagulant Therapy for STEMI | – | Anticoagulant Therapy for STEMI |
Cardiology | Stemi | Immediate Adjunctive Therapy for STEMI | – | Immediate Adjunctive Therapy for STEMI |
Cardiology | Stemi | LV failure | – | – |
Cardiology | Stemi | Inferior MI complications | – | – |
Cardiology | Stemi | Mechanical complications | – | – |
Cardiology | Stemi | Post-MI Arrhythmias | – | Other Post-MI Complications |
Cardiology | Stemi | Prognosis based on Killip Class | – | Prognosis based on Killip Class |
Cardiology | Stemi | Prognosis based on Forrester Class | – | Prognosis based on Forrester Class |
Cardiology | Pre-discharge checklist and long-term post-acs management | Risk stratification | – | – |
Cardiology | Pre-discharge checklist and long-term post-acs management | Medications (barring contraindications) | – | – |
Cardiology | Pre-discharge checklist and long-term post-acs management | ICD | – | – |
Cardiology | Pre-discharge checklist and long-term post-acs management | Risk factors and lifestyle modifications | – | – |
Cardiology | Pa catheter and tailored therapy | Rationale | PA Catheter Waveforms | – |
Cardiology | Pa catheter and tailored therapy | Indications | – | – |
Cardiology | Pa catheter and tailored therapy | Efficacy concerns | – | – |
Cardiology | Pa catheter and tailored therapy | Placement | – | – |
Cardiology | Pa catheter and tailored therapy | Complications | – | – |
Cardiology | Pa catheter and tailored therapy | Intracardiac pressures | – | – |
Cardiology | Pa catheter and tailored therapy | Cardiac output | – | – |
Cardiology | Pa catheter and tailored therapy | Tailored therapy in cardiogenic shock | – | Hemodynamic Profiles of Various Forms of Shock |
Cardiology | Heart failure | Definitions | – | – |
Cardiology | Heart failure | History | – | – |
Cardiology | Heart failure | Functional classification (New York Heart Association class) | – | – |
Cardiology | Heart failure | Physical exam (“2-minute” hemodynamic profile) | – | – |
Cardiology | Heart failure | Evaluation for the presence of heart failure | – | – |
Cardiology | Heart failure | Evaluation of the causes of heart failure | Approach to left-sided heart failure | – |
Cardiology | Heart failure | Precipitants of acute heart failure | – | – |
Cardiology | Heart failure | Treatment of acute decompensated heart failure | – | Treatment of acute decompensated heart failure |
Cardiology | Heart failure | Treatment of advanced heart failure | – | Recommended Chronic Therapy by HF Stage |
Cardiology | Heart failure | Heart failure with reduced EF (HFrEF) | – | Treatment of HFrEF |
Cardiology | Heart failure | Heart failure with preserved EF (HFpEF) | – | – |
Cardiology | Dilated cardiomyopathy | Definition and epidemiology | – | – |
Cardiology | Dilated cardiomyopathy | Etiologies | – | – |
Cardiology | Dilated cardiomyopathy | Clinical manifestations | – | – |
Cardiology | Dilated cardiomyopathy | Diagnostic studies and workup | – | – |
Cardiology | Dilated cardiomyopathy | Treatment | – | – |
Cardiology | Hypertrophic cardiomyopathy | Definition and epidemiology | – | – |
Cardiology | Hypertrophic cardiomyopathy | Pathology | – | – |
Cardiology | Hypertrophic cardiomyopathy | Pathophysiology | – | – |
Cardiology | Hypertrophic cardiomyopathy | Clinical manifestations | – | – |
Cardiology | Hypertrophic cardiomyopathy | Physical exam | – | – |
Cardiology | Hypertrophic cardiomyopathy | Diagnostic studies | – | – |
Cardiology | Hypertrophic cardiomyopathy | Treatment | – | – |
Cardiology | Restrictive cardiomyopathy | Definition | – | – |
Cardiology | Restrictive cardiomyopathy | Etiology | – | – |
Cardiology | Restrictive cardiomyopathy | Pathology & pathophysiology | – | – |
Cardiology | Restrictive cardiomyopathy | Clinical manifestations | – | – |
Cardiology | Restrictive cardiomyopathy | Physical exam | – | – |
Cardiology | Restrictive cardiomyopathy | Diagnostic studies | – | – |
Cardiology | Restrictive cardiomyopathy | Treatment | – | – |
Cardiology | Aortic stenosis | Etiology | – | – |
Cardiology | Aortic stenosis | Clinical manifestations | – | – |
Cardiology | Aortic stenosis | Physical exam | Hemodynamics of Aortic Stenosis | – |
Cardiology | Aortic stenosis | Diagnostic studies | – | Classification of Aortic Stenosis |
Cardiology | Aortic stenosis | Treatment | – | – |
Cardiology | Aortic insufficiency | Etiology | – | – |
Cardiology | Aortic insufficiency | Clinical manifestations | – | Classic Eponymous Signs in Chronic Aortic Insufficiency |
Cardiology | Aortic insufficiency | Physical exam | Hemodynamics of Aortic Insufficiency | – |
Cardiology | Aortic insufficiency | Diagnostic studies | – | – |
Cardiology | Aortic insufficiency | Treatment | – | – |
Cardiology | Mitral regurgitation | Etiology | – | – |
Cardiology | Mitral regurgitation | Clinical manifestations | – | – |
Cardiology | Mitral regurgitation | Physical exam | Hemodynamics of Mitral Regurgitation | – |
Cardiology | Mitral regurgitation | Diagnostic studies | – | Classification of Mitral Regurgitation |
Cardiology | Mitral regurgitation | Treatment | – | – |
Cardiology | Mitral stenosis | Etiology | – | – |
Cardiology | Mitral stenosis | Clinical manifestations | – | – |
Cardiology | Mitral stenosis | Physical exam | Hemodynamics of Mitral Stenosis | – |
Cardiology | Mitral stenosis | Diagnostic studies | – | Classification of Mitral Stenosis |
Cardiology | Mitral stenosis | Treatment | – | – |
Cardiology | Mitral valve prolapse | Definition and etiology | – | – |
Cardiology | Mitral valve prolapse | Clinical manifestations | – | – |
Cardiology | Mitral valve prolapse | Physical exam | – | – |
Cardiology | Mitral valve prolapse | Treatment | – | – |
Cardiology | Tricuspid regurgitation | Tricuspid regurgitation | – | – |
Cardiology | Prosthetic heart valves | Mechanical | Superior View of Heart Valves | – |
Cardiology | Prosthetic heart valves | Bioprosthetic | – | – |
Cardiology | Prosthetic heart valves | Physical exam | – | – |
Cardiology | Prosthetic heart valves | Anticoagulation & antiplatelet therapy | – | Periprocedural Bridging of Anticoagulation in Pts with MV |
Cardiology | Prosthetic heart valves | Correction of overanticoagulation | – | – |
Cardiology | Prosthetic heart valves | Endocarditis prophylaxis | – | – |
Cardiology | Prosthetic heart valves | Complications | – | – |
Cardiology | Pericardial disease | Anatomy | – | – |
Cardiology | Pericardial disease | Disease states | – | – |
Cardiology | Pericarditis and pericardial effusion | Etiology | – | Etiologies of Acute Pericarditis |
Cardiology | Pericarditis and pericardial effusion | Clinical manifestations | – | – |
Cardiology | Pericarditis and pericardial effusion | Physical exam | – | – |
Cardiology | Pericarditis and pericardial effusion | Diagnostic studies | – | – |
Cardiology | Pericarditis and pericardial effusion | Workup for effusion | – | – |
Cardiology | Pericarditis and pericardial effusion | Treatment of pericarditis | – | – |
Cardiology | Pericardial tamponade | Etiology | – | – |
Cardiology | Pericardial tamponade | Pathophysiology | – | – |
Cardiology | Pericardial tamponade | Clinical manifestations | – | – |
Cardiology | Pericardial tamponade | Physical exam | – | – |
Cardiology | Pericardial tamponade | Diagnostic studies | – | – |
Cardiology | Pericardial tamponade | Treatment | – | – |
Cardiology | Constrictive pericarditis | Etiology | – | Constrictive Pericarditis vs Restrictive Cardiomyopathy |
Cardiology | Constrictive pericarditis | Pathophysiology | – | – |
Cardiology | Constrictive pericarditis | Clinical manifestations | – | – |
Cardiology | Constrictive pericarditis | Physical exam | – | – |
Cardiology | Constrictive pericarditis | Diagnostic studies | – | – |
Cardiology | Constrictive pericarditis | Treatment | – | – |
Cardiology | Hypertension | Classification | – | JNC VII Classification of Hypertension |
Cardiology | Hypertension | Epidemiology | – | – |
Cardiology | Hypertension | Etiologies | – | Secondary Causes of Hypertension |
Cardiology | Hypertension | Standard workup | – | – |
Cardiology | Hypertension | Complications of HTN | – | – |
Cardiology | Hypertension | Treatment | – | – |
Cardiology | Hypertensive crises | Definitions | – | – |
Cardiology | Hypertensive crises | Precipitants | – | – |
Cardiology | Hypertensive crises | Treatment | – | Drugs for Hypertensive Crises |
Cardiology | Aortic aneurysms | Definitions | – | – |
Cardiology | Aortic aneurysms | Epidemiology | – | – |
Cardiology | Aortic aneurysms | Pathophysiology | – | – |
Cardiology | Aortic aneurysms | Screening | – | – |
Cardiology | Aortic aneurysms | Diagnostic studies | – | – |
Cardiology | Aortic aneurysms | Treatment | – | – |
Cardiology | Acute aortic syndromes | Definitions | – | – |
Cardiology | Acute aortic syndromes | Classification | – | – |
Cardiology | Acute aortic syndromes | Risk factors | – | – |
Cardiology | Acute aortic syndromes | Clinical manifestations | – | Clinical Manifestations and Physical Exam of Acute Aortic Syndromes |
Cardiology | Acute aortic syndromes | Diagnostic studies | – | – |
Cardiology | Acute aortic syndromes | Treatment | – | – |
Cardiology | Acute aortic syndromes | Complications | – | – |
Cardiology | Bradycardias, av block, and av dissociation | Sinus bradycardia (SB) | – | – |
Cardiology | Bradycardias, av block, and av dissociation | Sick sinus syndrome (SSS) | – | – |
Cardiology | Bradycardias, av block, and av dissociation | AV Block | – | Classification of AV Block |
Cardiology | Bradycardias, av block, and av dissociation | AV Dissociation | – | – |
Cardiology | Bradycardias, av block, and av dissociation | Temporary pacing wires | – | – |
Cardiology | Supraventricular tachycardias | Approach | – | Approach to SVT |
Cardiology | Supraventricular tachycardias | Etiology | – | Common Etiologies of SVT |
Cardiology | Supraventricular tachycardias | Diagnosis | – | Diagnosis of SVT |
Cardiology | Supraventricular tachycardias | Treatment | – | Treatment of SVT |
Cardiology | Accessory pathways (wolff-parkinson-white) | Definitions | Delta wave of WPW Syndrome | – |
Cardiology | Accessory pathways (wolff-parkinson-white) | Classic tachycardias of WPW | – | – |
Cardiology | Accessory pathways (wolff-parkinson-white) | Treatment | – | – |
Cardiology | Wide-complex tachycardias | Etiology | – | – |
Cardiology | Wide-complex tachycardias | Monomorphic ventricular tachycardia (MMVT) | Epsilon wave in ARVD | – |
Cardiology | Wide-complex tachycardias | Polymorphic ventricular tachycardia (PMVT) | ECG of Brugada Syndrome | – |
Cardiology | Wide-complex tachycardias | Diagnostic clues that favor VT (assume until proven o/w) | – | – |
Cardiology | Wide-complex tachycardias | Long-term management | – | – |
Cardiology | Atrial fibrillation | Classification | – | – |
Cardiology | Atrial fibrillation | Epidemiology and etiologies | – | – |
Cardiology | Atrial fibrillation | Evaluation | – | Approach to Acute AF |
Cardiology | Atrial fibrillation | Strategies for recurrent AF | – | Rate Control for AF |
Cardiology | Atrial fibrillation | Cardioversion | – | Antiarrhythmic Drugs for AF |
Cardiology | Atrial fibrillation | Nonpharmacologic therapy | – | – |
Cardiology | Atrial fibrillation | Oral anticoagulation | – | Novel Oral Anticoagulants for Nonvalvular AF |
Cardiology | Syncope | Definition | – | – |
Cardiology | Syncope | Etiologies | – | – |
Cardiology | Syncope | Workup | Approach to Syncope | – |
Cardiology | Syncope | Other diagnostic studies | – | – |
Cardiology | Syncope | High-risk features | – | – |
Cardiology | Syncope | Treatment | – | – |
Cardiology | Syncope | Prognosis | – | – |
Cardiology | Intracardiac devices | Pacemaker Code | – | Pacemaker Code |
Cardiology | Intracardiac devices | Common Pacing Modes | – | Common Pacing Modes |
Cardiology | Intracardiac devices | Indications for Permanent Pacing | – | Indications for Permanent Pacing |
Cardiology | Intracardiac devices | Permanent Pacemaker Complications | – | Permanent Pacemaker Complications |
Cardiology | Intracardiac devices | Cardiac resynch therapy (CRT)/Biventricular (BiV) pacing | – | – |
Cardiology | Intracardiac devices | Implantable cardiac defibrillator (ICD) | – | – |
Cardiology | Intracardiac devices | Device infection | – | – |
Cardiology | Cardiac risk assessment for noncardiac surgery | Clinical Assessment | – | Clinical Assessment |
Cardiology | Cardiac risk assessment for noncardiac surgery | Surgery-Specific Risk | – | Surgery-Specific Risk |
Cardiology | Cardiac risk assessment for noncardiac surgery | Functional Capacity | – | Functional Capacity |
Cardiology | Cardiac risk assessment for noncardiac surgery | Noninvasive Testing Result | – | Noninvasive Testing Result |
Cardiology | Cardiac risk assessment for noncardiac surgery | Preoperative evaluation | ACC/AHA approach to preoperative cardiovascular evaluation for noncardiac surgery | – |
Cardiology | Cardiac risk assessment for noncardiac surgery | Preoperative testing and assessment | – | – |
Cardiology | Cardiac risk assessment for noncardiac surgery | Pre- & perioperative management | – | – |
Cardiology | Cardiac risk assessment for noncardiac surgery | Perioperative β-blocker | – | – |
Cardiology | Cardiac risk assessment for noncardiac surgery | Postoperative monitoring | – | – |
Cardiology | Peripheral artery disease | Clinical features | – | – |
Cardiology | Peripheral artery disease | Diagnosis | – | – |
Cardiology | Peripheral artery disease | Treatment | – | – |
Cardiology | Peripheral artery disease | Acute limb ischemia (ALI) | – | – |
Pulmonary | Dyspnea | Etiologies | – | Etiologies of Dyspnea |
Pulmonary | Dyspnea | Evaluation | – | – |
Pulmonary | Pulmonary function tests | Approach to abnormal PFTs | Approach to abnormal PFTs | – |
Pulmonary | Asthma | Definition and epidemiology | – | – |
Pulmonary | Asthma | Clinical manifestations | – | – |
Pulmonary | Asthma | Physical examination | – | – |
Pulmonary | Asthma | Diagnostic studies | – | – |
Pulmonary | Asthma | Ddx | – | – |
Pulmonary | Asthma | “Asthma plus” syndromes | – | – |
Pulmonary | Asthma | “Reliever” medications | – | – |
Pulmonary | Asthma | “Controller” meds | – | – |
Pulmonary | Asthma | Other | – | – |
Pulmonary | Asthma | Principles of treatment | – | Asthma Stepwise Therapy |
Pulmonary | Asthma exacerbation | Evaluation | – | Severity of Asthma Exacerbation |
Pulmonary | Asthma exacerbation | Initial treatment | Disposition of patients after initial treatment of asthma exacerbation | – |
Pulmonary | Asthma exacerbation | ICU-level care | – | – |
Pulmonary | Anaphylaxis | Definition and pathophysiology | – | – |
Pulmonary | Anaphylaxis | Diagnosis | – | – |
Pulmonary | Anaphylaxis | Treatment | – | – |
Pulmonary | Anaphylaxis | Disposition | – | – |
Pulmonary | Chronic obstructive pulmonary disease | Definition and epidemiology | – | Emphysema vs Chronic Bronchitis |
Pulmonary | Chronic obstructive pulmonary disease | Pathogenesis | – | – |
Pulmonary | Chronic obstructive pulmonary disease | Clinical manifestations | – | – |
Pulmonary | Chronic obstructive pulmonary disease | Diagnostic studies | – | – |
Pulmonary | Chronic obstructive pulmonary disease | Chronic treatment | – | – |
Pulmonary | Chronic obstructive pulmonary disease | Staging and prognosis | – | COPD Staging and Recommended Therapies by GOLD Criteria |
Pulmonary | Chronic obstructive pulmonary disease | Exacerbation | – | COPD Exacerbation Treatment |
Pulmonary | Hemoptysis | Definition and pathophysiology | – | – |
Pulmonary | Hemoptysis | Etiologies | – | Etiologies of Hemoptysis |
Pulmonary | Hemoptysis | Diagnostic workup | – | – |
Pulmonary | Hemoptysis | Treatment | – | – |
Pulmonary | Bronchiectasis | Definition and epidemiology | – | – |
Pulmonary | Bronchiectasis | Initial workup | – | Etiologies of Bronchiectasis |
Pulmonary | Bronchiectasis | Treatment | – | – |
Pulmonary | Solitary pulmonary nodule | Principles | – | Etiologies of SPN |
Pulmonary | Solitary pulmonary nodule | Initial evaluation | – | – |
Pulmonary | Solitary pulmonary nodule | Diagnostic studies | – | – |
Pulmonary | Solitary pulmonary nodule | Management | – | – |
Pulmonary | Obstructive sleep apnea | Definition and pathophysiology | – | – |
Pulmonary | Obstructive sleep apnea | Clinical manifestations | – | – |
Pulmonary | Obstructive sleep apnea | Diagnosis and treatment | – | – |
Pulmonary | Interstitial lung disease | Workup of ILD | – | – |
Pulmonary | Interstitial lung disease | Etiologies of ILD | – | Clinical Manifestations of Sarcoidosis |
Pulmonary | Interstitial lung disease | Idiopathic Interstitial Pneumonias | – | Classification of Idiopathic Interstitial Pneumonia |
Pulmonary | Pleural effusion | Pathophysiology | – | – |
Pulmonary | Pleural effusion | Transudates | – | – |
Pulmonary | Pleural effusion | Exudates | – | – |
Pulmonary | Pleural effusion | Diagnostic studies | – | Characteristics of Pleural Fluid |
Pulmonary | Pleural effusion | Treatment | – | – |
Pulmonary | Venous thromboembolism | Definitions | – | – |
Pulmonary | Venous thromboembolism | Risk factors | – | Thromboprophylaxis |
Pulmonary | Venous thromboembolism | Clinical manifestations—DVT | – | Simplified Wells Pretest Probability Scoring for DVT |
Pulmonary | Venous thromboembolism | Diagnostic studies—DVT | Approach to Suspected DVT | – |
Pulmonary | Venous thromboembolism | Clinical manifestations—PE | – | Simplified Wells Pretest Probability Scoring for PE |
Pulmonary | Venous thromboembolism | Diagnostic studies—PE | Approach to Suspected PE using CTA | – |
Pulmonary | Venous thromboembolism | Workup for idiopathic VTE | – | – |
Pulmonary | Venous thromboembolism | Risk stratification for Pts with PE | – | – |
Pulmonary | Venous thromboembolism | Treatment of VTE | – | – |
Pulmonary | Venous thromboembolism | Complications & prognosis | – | – |
Pulmonary | Pulmonary hypertension | Pathobiology | – | Etiologies of Pulmonary Hypertension |
Pulmonary | Pulmonary hypertension | Clinical manifestations | – | – |
Pulmonary | Pulmonary hypertension | Physical exam | – | – |
Pulmonary | Pulmonary hypertension | Diagnostic studies & workup | – | – |
Pulmonary | Pulmonary hypertension | Treatment | Treatment of PAH | – |
Pulmonary | Pulmonary hypertension | Treatment | – | Vasoactive Agents for PAH |
Pulmonary | Pulmonary hypertension | Management of ICU patient | – | – |
Pulmonary | Pulmonary hypertension | Prognosis | – | – |
Pulmonary | Respiratory failure | Hypoxia | Workup of acute hypoxemia | – |
Pulmonary | Respiratory failure | Chemical Causes of Cellular Hypoxia | – | Chemical Causes of Cellular Hypoxia |
Pulmonary | Respiratory failure | Hypercapnia | – | Etiologies of Hypercapnia |
Pulmonary | Mechanical ventilation | Indications | – | – |
Pulmonary | Mechanical ventilation | Choosing settings | – | – |
Pulmonary | Mechanical ventilation | Pick Ventilator Mode | – | Pick Ventilator Mode |
Pulmonary | Mechanical ventilation | Choose Volume Targeted or Pressure Targeted | – | Choose Volume Targeted or Pressure Targeted |
Pulmonary | Mechanical ventilation | Set Remaining Variables | – | Set Remaining Variables |
Pulmonary | Mechanical ventilation | Initial Settings | – | Initial Settings |
Pulmonary | Mechanical ventilation | Noninvasive CPAP/Ventilation | – | Noninvasive CPAP/Ventilation |
Pulmonary | Mechanical ventilation | Tailoring the ventilator settings | – | – |
Pulmonary | Mechanical ventilation | Acute ventilatory deterioration | Approach to acute ventilatory deterioration | – |
Pulmonary | Mechanical ventilation | Weaning from the ventilator | – | – |
Pulmonary | Mechanical ventilation | Complications | – | – |
Pulmonary | Acute respiratory distress syndrome | New “Berlin” definition | – | – |
Pulmonary | Acute respiratory distress syndrome | Pathophysiology | – | Etiologies of ARDS |
Pulmonary | Acute respiratory distress syndrome | Treatment | – | Ventilator Strategies by VILI Mechanisms |
Pulmonary | Acute respiratory distress syndrome | Prognosis | – | – |
Pulmonary | Sepsis | Definitions | – | Sepsis Definitions |
Pulmonary | Sepsis | Fluids & vasoactive drugs | – | – |
Pulmonary | Sepsis | Antibiotics | – | – |
Pulmonary | Sepsis | Steroids | – | – |
Pulmonary | Sepsis | Activated protein C | – | – |
Pulmonary | Sepsis | Intensive glycemic control | – | – |
Gastroenterology | Dysphagia | Definitions | Etiologies of and approach to dysphagia | – |
Gastroenterology | Achalasia | Achalasia | – | – |
Gastroenterology | Other esophageal disorders | Other esophageal disorders | – | – |
Gastroenterology | Gastroesophageal reflux disease | Pathophysiology | – | – |
Gastroenterology | Gastroesophageal reflux disease | Clinical manifestations | – | – |
Gastroenterology | Gastroesophageal reflux disease | Diagnosis | – | – |
Gastroenterology | Gastroesophageal reflux disease | Treatment | – | – |
Gastroenterology | Gastroesophageal reflux disease | Complications | – | – |
Gastroenterology | Dyspepsia | Definition | – | – |
Gastroenterology | Dyspepsia | Etiologies | – | – |
Gastroenterology | Dyspepsia | Treatment of functional dyspepsia | – | – |
Gastroenterology | Peptic ulcer disease | Epidemiology & etiologies | – | – |
Gastroenterology | Peptic ulcer disease | Clinical manifestations | – | – |
Gastroenterology | Peptic ulcer disease | Diagnostic studies | – | – |
Gastroenterology | Peptic ulcer disease | Treatment | – | – |
Gastroenterology | Peptic ulcer disease | Prophylaxis if ASA/NSAID required | – | – |
Gastroenterology | Gastrointestinal bleeding | Definition | – | – |
Gastroenterology | Gastrointestinal bleeding | Etiologies of upper GI bleed (UGIB) | – | – |
Gastroenterology | Gastrointestinal bleeding | Etiologies of lower GI bleed (LGIB) | – | – |
Gastroenterology | Gastrointestinal bleeding | Clinical manifestations | – | – |
Gastroenterology | Gastrointestinal bleeding | Initial management | – | – |
Gastroenterology | Gastrointestinal bleeding | Workup | – | – |
Gastroenterology | Gastrointestinal bleeding | Diagnostic studies | – | – |
Gastroenterology | Gastrointestinal bleeding | Treatment of GIB by Etiologies | – | Treatment of GIB by Etiologies |
Gastroenterology | Gastrointestinal bleeding | Obscure GIB | – | – |
Gastroenterology | Acute diarrhea | Infectious Etiologies of Acute Diarrhea | – | Infectious Etiologies of Acute Diarrhea |
Gastroenterology | Acute diarrhea | Evaluation | – | – |
Gastroenterology | Acute diarrhea | Treatment | – | – |
Gastroenterology | Clostridium difficile-associated diarrhea | Pathogenesis | – | – |
Gastroenterology | Clostridium difficile-associated diarrhea | Clinical manifestations | – | – |
Gastroenterology | Clostridium difficile-associated diarrhea | Diagnosis | – | – |
Gastroenterology | Clostridium difficile-associated diarrhea | Treatment | – | – |
Gastroenterology | Chronic diarrhea | Medications | – | – |
Gastroenterology | Chronic diarrhea | Osmotic | – | – |
Gastroenterology | Chronic diarrhea | Malabsorption | – | – |
Gastroenterology | Chronic diarrhea | Inflammatory | – | – |
Gastroenterology | Chronic diarrhea | Secretory | – | – |
Gastroenterology | Chronic diarrhea | Motility | – | – |
Gastroenterology | Chronic diarrhea | Workup of chronic diarrhea | Workup of chronic diarrhea | – |
Gastroenterology | Constipation and adynamic ileus | Constipation | – | – |
Gastroenterology | Constipation and adynamic ileus | Acute pseudo-obstruction (adynamic ileus) | – | – |
Gastroenterology | Nutrition in hospitalized patients | Pathophysiology | – | – |
Gastroenterology | Nutrition in hospitalized patients | Critical illness | – | – |
Gastroenterology | Nutrition in hospitalized patients | End-stage liver disease | – | – |
Gastroenterology | Nutrition in hospitalized patients | Refeeding syndrome | – | – |
Gastroenterology | Diverticulosis | Definition & pathobiology | – | – |
Gastroenterology | Diverticulosis | Epidemiology | – | – |
Gastroenterology | Diverticulosis | Clinical manifestations | – | – |
Gastroenterology | Diverticulitis | Pathophysiology | – | – |
Gastroenterology | Diverticulitis | Clinical manifestations | – | – |
Gastroenterology | Diverticulitis | Diagnostic studies | – | – |
Gastroenterology | Diverticulitis | Treatment | – | – |
Gastroenterology | Diverticulitis | Prevention | – | – |
Gastroenterology | Diverticular hemorrhage | Pathophysiology | – | – |
Gastroenterology | Diverticular hemorrhage | Clinical manifestations | – | – |
Gastroenterology | Diverticular hemorrhage | Diagnostic studies | – | – |
Gastroenterology | Diverticular hemorrhage | Treatment | – | – |
Gastroenterology | Inflammatory bowel disease | Definition | – | – |
Gastroenterology | Inflammatory bowel disease | Epidemiology & pathophysiology | – | – |
Gastroenterology | Ulcerative colitis | Clinical manifestations | – | – |
Gastroenterology | Ulcerative colitis | Diagnosis | – | – |
Gastroenterology | Ulcerative colitis | Complications | – | – |
Gastroenterology | Ulcerative colitis | Prognosis | – | – |
Gastroenterology | Crohn's disease | Clinical manifestations | – | – |
Gastroenterology | Crohn's disease | Diagnosis | – | – |
Gastroenterology | Crohn's disease | Complications | – | – |
Gastroenterology | Crohn's disease | Prognosis | – | – |
Gastroenterology | Management of inflammatory bowel disease | Initial evaluation | – | IBD Induction of Remission |
Gastroenterology | Management of inflammatory bowel disease | Goals of treatment | – | IBD Maintenance of Remission |
Gastroenterology | Management of inflammatory bowel disease | Complications of therapy | – | – |
Gastroenterology | Management of inflammatory bowel disease | Cancer screening | – | – |
Gastroenterology | Acute mesenteric ischemia | Etiologies | – | – |
Gastroenterology | Acute mesenteric ischemia | Clinical manifestations | – | – |
Gastroenterology | Acute mesenteric ischemia | Physical exam | – | – |
Gastroenterology | Acute mesenteric ischemia | Diagnostic studies | – | – |
Gastroenterology | Acute mesenteric ischemia | Treatment | – | – |
Gastroenterology | Acute mesenteric ischemia | Prognosis | – | – |
Gastroenterology | Ischemic colitis | Definition & pathophysiology | – | – |
Gastroenterology | Ischemic colitis | Clinical manifestations, diagnosis, & treatment | – | – |
Gastroenterology | Pancreatitis | Pathogenesis | – | – |
Gastroenterology | Pancreatitis | Etiologies | – | – |
Gastroenterology | Pancreatitis | Clinical manifestations | – | – |
Gastroenterology | Pancreatitis | Physical exam | – | – |
Gastroenterology | Pancreatitis | Diagnostic studies | – | – |
Gastroenterology | Pancreatitis | Treatment | – | – |
Gastroenterology | Pancreatitis | Complications | – | Ranson's Criteria |
Gastroenterology | Pancreatitis | Prognosis | – | Pancreatitis Prognosis by Ranson's Criteria |
Gastroenterology | Pancreatitis | Chronic Pancreatitis | – | – |
Gastroenterology | Abnormal liver tests | Tests of hepatocellular injury or cholestasis | – | – |
Gastroenterology | Abnormal liver tests | Tests of hepatic function | – | – |
Gastroenterology | Abnormal liver tests | Patterns of liver injury | – | – |
Gastroenterology | Abnormal liver tests | Abnormal liver tests with hepatocellular pattern | Approach to abnormal liver tests with hepatocellular pattern | – |
Gastroenterology | Abnormal liver tests | Abnormal liver tests with cholestatic pattern | Approach to abnormal liver tests with cholestatic pattern | – |
Gastroenterology | Abnormal liver tests | Abnormal liver tests with isolated hyperbilirubinemia | Approach to abnormal liver tests with isolated hyperbilirubinemia | – |
Gastroenterology | Abnormal liver tests | Abnormal liver tests with infiltrated pattern | Approach to abnormal liver tests with infiltrated pattern | – |
Gastroenterology | Abnormal liver tests | Abnormal liver tests in asymptomatic patients | – | – |
Gastroenterology | Abnormal liver tests | Common medications that cause abnormal liver tests | – | Common medications that cause abnormal liver tests |
Gastroenterology | Viral hepatitis | Hepatitis A | – | – |
Gastroenterology | Viral hepatitis | Hepatitis B | Serologic Diagnosis of Hepatitis B | – |
Gastroenterology | Viral hepatitis | Hepatitis B | – | Serology of Hepatitis B |
Gastroenterology | Viral hepatitis | Hepatitis C | – | – |
Gastroenterology | Viral hepatitis | Hepatitis D | – | – |
Gastroenterology | Viral hepatitis | Hepatitis E | – | – |
Gastroenterology | Viral hepatitis | Other Viruses | – | – |
Gastroenterology | Autoimmune hepatitis | Classification | – | – |
Gastroenterology | Autoimmune hepatitis | Diagnosis and treatment | – | – |
Gastroenterology | Other causes of hepatitis or hepatotoxicity | Alcoholic hepatitis | – | – |
Gastroenterology | Other causes of hepatitis or hepatotoxicity | Acetaminophen hepatotoxicity | – | – |
Gastroenterology | Other causes of hepatitis or hepatotoxicity | Ischemic hepatitis | – | – |
Gastroenterology | Other causes of hepatitis or hepatotoxicity | Nonalcoholic fatty liver disease | – | – |
Gastroenterology | Acute liver failure | Definition | – | – |
Gastroenterology | Acute liver failure | Etiology | – | – |
Gastroenterology | Acute liver failure | Clinical manifestations | – | – |
Gastroenterology | Acute liver failure | Workup | – | – |
Gastroenterology | Acute liver failure | Treatment | – | – |
Gastroenterology | Acute liver failure | Prognosis | – | – |
Gastroenterology | Cirrhosis | Definition | – | – |
Gastroenterology | Cirrhosis | Etiologies | – | – |
Gastroenterology | Cirrhosis | Clinical manifestations | – | – |
Gastroenterology | Cirrhosis | Physical exam | – | – |
Gastroenterology | Cirrhosis | Laboratory studies | – | – |
Gastroenterology | Cirrhosis | Workup | – | – |
Gastroenterology | Cirrhosis | Ascites | – | – |
Gastroenterology | Cirrhosis | Spontaneous bacterial peritonitis | – | – |
Gastroenterology | Cirrhosis | Gastroesophageal varices ± UGIB | – | – |
Gastroenterology | Cirrhosis | Portosystemic encephalopathy (PSE) | – | – |
Gastroenterology | Cirrhosis | Hepatorenal syndrome (HRS) | – | – |
Gastroenterology | Cirrhosis | Hepatocellular carcinoma (HCC) | – | – |
Gastroenterology | Cirrhosis | Other complications | – | – |
Gastroenterology | Cirrhosis | Prognosis | – | Modified Child-Turcotte-Pugh Scoring System |
Gastroenterology | Cirrhosis | Liver transplantation | – | – |
Gastroenterology | Other etiologies of cirrhosis | Hemochromatosis | – | – |
Gastroenterology | Other etiologies of cirrhosis | Wilson's disease | – | – |
Gastroenterology | Other etiologies of cirrhosis | ɑ1-antitrypsin deficiency | – | – |
Gastroenterology | Other etiologies of cirrhosis | Primary biliary cirrhosis (PBC) | – | – |
Gastroenterology | Other etiologies of cirrhosis | Primary sclerosing cholangitis (PSC) | – | – |
Gastroenterology | Hepatic vascular disease | Portal vein thrombosis | – | – |
Gastroenterology | Hepatic vascular disease | Budd-Chiari syndrome | – | – |
Gastroenterology | Hepatic vascular disease | Sinusoidal obstruction syndrome | Hepatic vasculature | – |
Gastroenterology | Ascites | Pathophysiology | – | Etiologies of Ascites |
Gastroenterology | Ascites | Symptoms | – | – |
Gastroenterology | Ascites | Evaluation | – | – |
Gastroenterology | Ascites | Treatment | – | – |
Gastroenterology | Ascites | Bacterial peritonitis | – | Ascites in Bacterial peritonitis |
Gastroenterology | Cholelithiasis | Epidemiology & pathogenesis | – | – |
Gastroenterology | Cholelithiasis | Types of gallstones | – | – |
Gastroenterology | Cholelithiasis | Clinical manifestations | – | – |
Gastroenterology | Cholelithiasis | Diagnostic studies | – | – |
Gastroenterology | Cholelithiasis | Treatment | – | – |
Gastroenterology | Cholelithiasis | Complications | – | – |
Gastroenterology | Cholecystitis | Pathogenesis | – | – |
Gastroenterology | Cholecystitis | Clinical manifestations | – | – |
Gastroenterology | Cholecystitis | Diagnostic studies | – | – |
Gastroenterology | Cholecystitis | Treatment | – | – |
Gastroenterology | Cholecystitis | Complications | – | – |
Gastroenterology | Choledocholithiasis | Definition | – | – |
Gastroenterology | Choledocholithiasis | Epidemiology | – | – |
Gastroenterology | Choledocholithiasis | Clinical manifestations | – | – |
Gastroenterology | Choledocholithiasis | Diagnostic studies | – | – |
Gastroenterology | Choledocholithiasis | Treatment | – | – |
Gastroenterology | Choledocholithiasis | Complications | – | – |
Gastroenterology | Cholangitis | Definition & etiologies | – | – |
Gastroenterology | Cholangitis | Clinical manifestations | – | – |
Gastroenterology | Cholangitis | Diagnostic studies | – | – |
Gastroenterology | Cholangitis | Treatment | – | – |
Nephrology | Acid-base disturbances | Consequences of Severe Acid-Base Disturbances | – | Consequences of Severe Acid-Base Disturbances |
Nephrology | Acid-base disturbances | Workup | – | Acid-Base Disturbances |
Nephrology | Acid-base disturbances | Compensation for Acid-Base Disturbances | – | Compensation for Acid-Base Disturbances |
Nephrology | Acid-base disturbances | Acid-base nomogram | Acid-base nomogram | – |
Nephrology | Metabolic acidosis | Initial workup | Approach to metabolic acidosis | – |
Nephrology | Metabolic acidosis | Etiologies of AG metabolic acidosis | – | Etiologies of AG metabolic acidosis |
Nephrology | Metabolic acidosis | Workup for AG metabolic acidosis | – | Manifestations of ingestions causing AG metabolic acidosis |
Nephrology | Metabolic acidosis | Workup for non-AG metabolic acidosis | – | Etiologies of non-AG metabolic acidosis |
Nephrology | Metabolic acidosis | Renal tubular acidosis | – | Renal tubular acidosis |
Nephrology | Metabolic acidosis | Treatment of severe metabolic acidosis | – | – |
Nephrology | Metabolic alkalosis | Pathophysiology | – | – |
Nephrology | Metabolic alkalosis | Workup | Approach to metabolic alkalosis | – |
Nephrology | Metabolic alkalosis | Etiologies of metabolic alkalosis | – | Etiologies of metabolic alkalosis |
Nephrology | Metabolic alkalosis | Treatment of severe metabolic alkalosis | – | – |
Nephrology | Respiratory acidosis | Respiratory Acidosis | – | – |
Nephrology | Respiratory alkalosis | Respiratory Alkalosis | – | – |
Nephrology | Hyponatremia | Pathophysiology | Approach to hyponatremia | – |
Nephrology | Hyponatremia | Workup | – | – |
Nephrology | Hyponatremia | Hypovolemic hypotonic hyponatremia | – | – |
Nephrology | Hyponatremia | Euvolemic hypotonic hyponatremia | – | – |
Nephrology | Hyponatremia | Hypervolemic hypotonic hyponatremia | – | – |
Nephrology | Hyponatremia | Treatment | – | – |
Nephrology | Hypernatremia | Pathophysiology | Approach to hypernatremia | – |
Nephrology | Hypernatremia | Workup | – | – |
Nephrology | Hypernatremia | Extrarenal H2O loss | – | – |
Nephrology | Hypernatremia | Renal H2O loss | – | – |
Nephrology | Hypernatremia | Other | – | – |
Nephrology | Hypernatremia | Treatment | – | – |
Nephrology | Polyuria | Definition and pathophysiology | Approach to polyuria | – |
Nephrology | Polyuria | Workup | – | – |
Nephrology | Polyuria | Osmotic diuresis | – | – |
Nephrology | Polyuria | Water diuresis | – | – |
Nephrology | Polyuria | Treatment | – | – |
Nephrology | Hypokalemia | Transcellular shifts | Approach to hypokalemia | – |
Nephrology | Hypokalemia | GI potassium losses | – | – |
Nephrology | Hypokalemia | Renal potassium losses | – | – |
Nephrology | Hypokalemia | Clinical manifestations | – | – |
Nephrology | Hypokalemia | Workup | – | – |
Nephrology | Hypokalemia | Treatment | – | – |
Nephrology | Hyperkalemia | Transcellular shifts | – | – |
Nephrology | Hyperkalemia | Decreased GFR | – | – |
Nephrology | Hyperkalemia | Normal GFR but with Ø renal K excretion | – | – |
Nephrology | Hyperkalemia | Clinical manifestations | – | – |
Nephrology | Hyperkalemia | Workup | – | Treatment of Hyperkalemia |
Nephrology | Acute kidney injury | Definition | – | – |
Nephrology | Acute kidney injury | Workup | – | Etiologies and Diagnosis of Acute Kidney Injury |
Nephrology | Acute kidney injury | Contrast-induced acute kidney injury (CIAKI) | – | – |
Nephrology | Acute kidney injury | Treatment | – | – |
Nephrology | Chronic kidney disease | Definition and etiologies | – | Stages of CKD |
Nephrology | Chronic kidney disease | Treatment | – | Signs and Symptoms of Uremia |
Nephrology | Diuresis | General considerations | – | Approach to Diuresis |
Nephrology | Diuresis | Loop diuretics | – | – |
Nephrology | Diuresis | Thiazide diuretics | – | – |
Nephrology | Diuresis | K-sparing diuretics | – | – |
Nephrology | Diuresis | Disease state specific regimens | – | – |
Nephrology | Diuresis | Adverse effects | – | – |
Nephrology | Renal replacement and dialysis | General | – | – |
Nephrology | Renal replacement and dialysis | Hemodialysis (HD) | – | – |
Nephrology | Renal replacement and dialysis | Continuous veno-venous hemofiltration (CVVH) | – | – |
Nephrology | Renal replacement and dialysis | Peritoneal dialysis (PD) | – | – |
Nephrology | Renal replacement and dialysis | Kidney transplantation | – | – |
Nephrology | Glomerulonephritis | Definition | Approach to glomerulonephritis | – |
Nephrology | Glomerulonephritis | ANCA-Positive Vasculitis | – | ANCA-Positive Vasculitis |
Nephrology | Glomerulonephritis | Anti-GBM Disease | – | Anti-GBM Disease |
Nephrology | Glomerulonephritis | Immune Complex Disease | – | Immune Complex Disease |
Nephrology | Glomerulonephritis | Workup | – | – |
Nephrology | Glomerulonephritis | Treatment | – | – |
Nephrology | Asymptomatic glomerular hematuria | Definition and etiologies | – | – |
Nephrology | Asymptomatic glomerular hematuria | IgA nephropathy | – | – |
Nephrology | Nephrotic syndrome | Definition | – | – |
Nephrology | Nephrotic syndrome | Primary glomerular diseases | – | – |
Nephrology | Nephrotic syndrome | Systemic diseases | – | – |
Nephrology | Nephrotic syndrome | Workup | – | – |
Nephrology | Nephrotic syndrome | Treatment | – | – |
Nephrology | Urinalysis | Urine Dipstick | – | Urine Dipstick |
Nephrology | Urinalysis | Urine Sediment | – | Urine Sediment |
Nephrology | Proteinuria | Proteinuria | – | Etiologies of Proteinuria |
Nephrology | Hematuria | Workup | – | Etiologies of Hematuria |
Nephrology | Nephrolithiasis | Types of stones and risk factors | – | – |
Nephrology | Nephrolithiasis | Clinical manifestations | – | – |
Nephrology | Nephrolithiasis | Workup | – | – |
Nephrology | Nephrolithiasis | Acute treatment | – | – |
Nephrology | Nephrolithiasis | Chronic treatment | – | – |
Hematology-Oncology | Anemia | Clinical manifestations | – | – |
Hematology-Oncology | Anemia | Diagnostic evaluation | Approach to anemia | – |
Hematology-Oncology | Microcytic anemia | Approach to microcytic anemias | Approach to microcytic anemias | – |
Hematology-Oncology | Microcytic anemia | Iron deficiency | – | – |
Hematology-Oncology | Microcytic anemia | Thalassemias | – | – |
Hematology-Oncology | Microcytic anemia | Anemia of chronic inflammation | – | – |
Hematology-Oncology | Microcytic anemia | Sideroblastic anemia | – | – |
Hematology-Oncology | Normocytic anemia | Pancytopenia | – | – |
Hematology-Oncology | Normocytic anemia | Anemia of chronic inflammation | – | – |
Hematology-Oncology | Normocytic anemia | Anemias of chronic disorders | – | – |
Hematology-Oncology | Normocytic anemia | Sideroblastic anemia | – | – |
Hematology-Oncology | Normocytic anemia | Pure red cell aplasia | – | – |
Hematology-Oncology | Macrocytic anemia | Megaloblastic anemia | – | – |
Hematology-Oncology | Macrocytic anemia | Folate deficiency | – | – |
Hematology-Oncology | Macrocytic anemia | Vitamin B12 deficiency | – | – |
Hematology-Oncology | Macrocytic anemia | Nonmegaloblastic macrocytic anemias | – | – |
Hematology-Oncology | Pancytopenia | Etiologies | – | – |
Hematology-Oncology | Pancytopenia | Clinical manifestations | – | – |
Hematology-Oncology | Pancytopenia | Aplastic anemia | – | – |
Hematology-Oncology | Pancytopenia | Myelodysplastic syndromes (MDS) | – | – |
Hematology-Oncology | Pancytopenia | Paroxysmal nocturnal hemoglobinuria (PNH) | – | – |
Hematology-Oncology | Pancytopenia | Myelophthisic anemia | – | – |
Hematology-Oncology | Hemolytic anemia | Diagnostic evaluation | – | Causes of Hemolytic Anemia by Mechanism |
Hematology-Oncology | Hemolytic anemia | Glucose-6-phosphate dehydrogenase (G6PD) deficiency | – | – |
Hematology-Oncology | Hemolytic anemia | Sickle cell anemia | – | – |
Hematology-Oncology | Hemolytic anemia | Hereditary spherocytosis (HS) | – | – |
Hematology-Oncology | Hemolytic anemia | Autoimmune hemolytic anemia (AIHA) | – | – |
Hematology-Oncology | Hemolytic anemia | Drug-induced hemolytic anemia | – | – |
Hematology-Oncology | Hemolytic anemia | Microangiopathic hemolytic anemia (MAHA) | – | – |
Hematology-Oncology | Hemolytic anemia | Hypersplenism | – | Causes of Splenomegaly |
Hematology-Oncology | Disorders of hemostasis | Approach to abnormal hemostasis | Approach to abnormal hemostasis | – |
Hematology-Oncology | Disorders of hemostasis | Clinical Characteristics of Bleeding Disorders | – | Clinical Characteristics of Bleeding Disorders |
Hematology-Oncology | Disorders of hemostasis | Coagulation Cascade | Coagulation Cascade | – |
Hematology-Oncology | Disorders of hemostasis | Purpura | – | – |
Hematology-Oncology | Thrombocytopenia | Etiologies | Approach to thrombocytopenia | – |
Hematology-Oncology | Thrombocytopenia | Thrombocytopenia and Risk of Bleeding | – | Thrombocytopenia and Risk of Bleeding |
Hematology-Oncology | Thrombocytopenia | Diagnostic evaluation | – | – |
Hematology-Oncology | Thrombocytopenia | Primary immune thrombocytopenic purpura (ITP) | – | Treatment of Primary ITP in Adults |
Hematology-Oncology | Thrombocytopenia | Heparin-Induced Thrombocytopenia | – | Overview of Heparin-Induced Thrombocytopenia |
Hematology-Oncology | Thrombocytopenia | Evaluation of Suspected HIT | – | Evaluation of Suspected HIT |
Hematology-Oncology | Thrombocytopenia | Hemolytic-uremic syndrome (HUS) | – | – |
Hematology-Oncology | Thrombocytopenia | Thrombotic thrombocytopenic purpura (TTP) | – | – |
Hematology-Oncology | Disorders of platelet function | Tests of platelet function | – | Mechanisms and Etiologies of Platelet Function Abnormalities |
Hematology-Oncology | Disorders of platelet function | von Willebrand’s disease (vWD) | – | – |
Hematology-Oncology | Disorders of platelet function | Uremic bleeding | – | – |
Hematology-Oncology | Coagulopathies | Screening Test Abnormalities in Inherited and Acquired Coagulopathies | – | Screening Test Abnormalities in Inherited and Acquired Coagulopathies |
Hematology-Oncology | Coagulopathies | Further coagulation tests | – | – |
Hematology-Oncology | Coagulopathies | Hemophilias | – | – |
Hematology-Oncology | Coagulopathies | Coagulation factor inhibitors | – | – |
Hematology-Oncology | Coagulopathies | Disseminated intravascular coagulation (DIC) | – | – |
Hematology-Oncology | Coagulopathies | Vitamin K deficiency | – | Properties and Antidotes for Anticoagulants and Fibrinolytics |
Hematology-Oncology | Hypercoagulable states | Inherited Hypercoagulable States | – | Inherited Hypercoagulable States |
Hematology-Oncology | Hypercoagulable states | Vascular Beds Affected by Inherited and Acquired Hypercoagulable States | – | Vascular Beds Affected by Inherited and Acquired Hypercoagulable States |
Hematology-Oncology | Hypercoagulable states | Diagnostic evaluation | – | – |
Hematology-Oncology | Hypercoagulable states | Treatment | – | – |
Hematology-Oncology | Hypercoagulable states | Antiphospholipid syndrome (APS) | – | – |
Hematology-Oncology | Disorders of leukocytes | Neutrophilia | – | Neutrophilia |
Hematology-Oncology | Disorders of leukocytes | Neutropenia | – | Neutropenia |
Hematology-Oncology | Disorders of leukocytes | Lymphocytosis | – | Lymphocytosis |
Hematology-Oncology | Disorders of leukocytes | Monocytosis | – | Monocytosis |
Hematology-Oncology | Disorders of leukocytes | Eosinophilia | – | Eosinophilia |
Hematology-Oncology | Disorders of leukocytes | Basophilia | – | Basophilia |
Hematology-Oncology | Disorders of leukocytes | Lymphadenopathy | – | Lymphadenopathy |
Hematology-Oncology | Transfusion therapy | Blood Products and Indications | – | Blood Products and Indications |
Hematology-Oncology | Transfusion therapy | Transfusion Complications | – | Transfusion Complications |
Hematology-Oncology | Transfusion therapy | Transfusion Reactions | – | Transfusion Reactions |
Hematology-Oncology | Myelodysplastic syndromes | Myeloid neoplasm overview | – | WHO 2008 Myeloid Neoplasm Categories |
Hematology-Oncology | Myelodysplastic syndromes | Myelodysplastic syndromes (MDS) overview | – | WHO 2008 Classification Systems for MDS |
Hematology-Oncology | Myelodysplastic syndromes | Revised International Prognostic Scoring System | – | Revised International Prognostic Scoring System for AML |
Hematology-Oncology | Myeloproliferative neoplasms (mpn) | Myeloproliferative Neoplasms (MPN) | – | – |
Hematology-Oncology | Polycythemia vera (pv) | Definition | – | – |
Hematology-Oncology | Polycythemia vera (pv) | Etiologies of erythrocytosis | – | – |
Hematology-Oncology | Polycythemia vera (pv) | Clinical manifestations | – | – |
Hematology-Oncology | Polycythemia vera (pv) | Diagnostic evaluation | – | – |
Hematology-Oncology | Polycythemia vera (pv) | Treatment | – | – |
Hematology-Oncology | Polycythemia vera (pv) | Prognosis | – | – |
Hematology-Oncology | Essential thrombocythemia (et) | Definition | – | – |
Hematology-Oncology | Essential thrombocythemia (et) | Etiologies of thrombocytosis | – | – |
Hematology-Oncology | Essential thrombocythemia (et) | Clinical manifestations | – | – |
Hematology-Oncology | Essential thrombocythemia (et) | Diagnostic evaluation | – | – |
Hematology-Oncology | Essential thrombocythemia (et) | Prognosis | – | – |
Hematology-Oncology | Primary myelofibrosis (pmf) | Definition | – | – |
Hematology-Oncology | Primary myelofibrosis (pmf) | Etiologies of myelofibrosis | – | – |
Hematology-Oncology | Primary myelofibrosis (pmf) | Clinical manifestations | – | – |
Hematology-Oncology | Primary myelofibrosis (pmf) | Diagnostic evaluation | – | – |
Hematology-Oncology | Primary myelofibrosis (pmf) | Treatment | – | – |
Hematology-Oncology | Primary myelofibrosis (pmf) | Complications and prognosis | – | – |
Hematology-Oncology | Acute leukemia | Definition | – | – |
Hematology-Oncology | Acute leukemia | Epidemiology and risk factors | – | – |
Hematology-Oncology | Acute leukemia | Clinical manifestations | – | – |
Hematology-Oncology | Acute leukemia | Diagnostic evaluation | – | – |
Hematology-Oncology | Acute myelogenous leukemia (aml) | Classification | – | WHO 2008 Classification of AML |
Hematology-Oncology | Acute myelogenous leukemia (aml) | Treatment | – | AML Genetics |
Hematology-Oncology | Acute myelogenous leukemia (aml) | Prognosis | – | – |
Hematology-Oncology | Acute myelogenous leukemia (aml) | Acute Promyelocytic Leukemia (APL) | – | – |
Hematology-Oncology | Acute lymphoblastic leukemia (all) | Classification | – | WHO Immunophenotype Classification of ALL |
Hematology-Oncology | Acute lymphoblastic leukemia (all) | Treatment | – | – |
Hematology-Oncology | Acute lymphoblastic leukemia (all) | Prognosis | – | – |
Hematology-Oncology | Chronic myelogenous leukemia (cml) | Definition | – | – |
Hematology-Oncology | Chronic myelogenous leukemia (cml) | Epidemiology and risk factors | – | – |
Hematology-Oncology | Chronic myelogenous leukemia (cml) | Clinical manifestations | – | – |
Hematology-Oncology | Chronic myelogenous leukemia (cml) | Diagnostic evaluation | – | – |
Hematology-Oncology | Chronic myelogenous leukemia (cml) | Treatment | – | Goals of TKI Therapy |
Hematology-Oncology | Chronic myelogenous leukemia (cml) | Prognosis | – | – |
Hematology-Oncology | Chronic lymphocytic leukemia (cll) | Definition | – | – |
Hematology-Oncology | Chronic lymphocytic leukemia (cll) | Epidemiology and risk factors | – | – |
Hematology-Oncology | Chronic lymphocytic leukemia (cll) | Clinical manifestations | – | – |
Hematology-Oncology | Chronic lymphocytic leukemia (cll) | Diagnostic evaluation | – | CLL Staging |
Hematology-Oncology | Chronic lymphocytic leukemia (cll) | Treatment | – | – |
Hematology-Oncology | Chronic lymphocytic leukemia (cll) | Prognosis | – | – |
Hematology-Oncology | Lymphoma | Definition | – | – |
Hematology-Oncology | Lymphoma | Clinical manifestations | – | – |
Hematology-Oncology | Lymphoma | Diagnostic and staging evaluation | – | Ann Arbor Staging System with Cotswolds Modifications |
Hematology-Oncology | Hodgkin lymphoma (hl) | Epidemiology and risk factors | – | – |
Hematology-Oncology | Hodgkin lymphoma (hl) | Pathology | – | WHO Histologic Classification of Classical HL |
Hematology-Oncology | Hodgkin lymphoma (hl) | Treatment | – | International Prognostic Score (IPS) |
Hematology-Oncology | Non-hodgkin lymphoma (nhl) | Epidemiology and risk factors | – | WHO Classification of Lymphoid Malignancies |
Hematology-Oncology | Non-hodgkin lymphoma (nhl) | Treatment | – | – |
Hematology-Oncology | Non-hodgkin lymphoma (nhl) | Prognosis | – | Follicular Lymphoma International Prognostic Index (FLIPI) |
Hematology-Oncology | Non-hodgkin lymphoma (nhl) | HIV-associated NHL | – | International Prognostic Index (IPI) for Aggressive NHL |
Hematology-Oncology | Multiple myeloma | Definition and epidemiology | – | – |
Hematology-Oncology | Multiple myeloma | Clinical manifestations | – | – |
Hematology-Oncology | Multiple myeloma | Diagnostic and staging evaluation | – | Multiple Myeloma Staging Systems |
Hematology-Oncology | Multiple myeloma | Treatment | – | – |
Hematology-Oncology | Monoclonal gammopathy of uncertain significance | Definition and epidemiology | – | – |
Hematology-Oncology | Monoclonal gammopathy of uncertain significance | Management | – | – |
Hematology-Oncology | Monoclonal gammopathy of uncertain significance | Prognosis | – | – |
Hematology-Oncology | Waldenstrom's macroglobulinemia | Definition | – | – |
Hematology-Oncology | Waldenstrom's macroglobulinemia | Clinical manifestations | – | – |
Hematology-Oncology | Waldenstrom's macroglobulinemia | Diagnostic evaluation | – | – |
Hematology-Oncology | Waldenstrom's macroglobulinemia | Treatment | – | – |
Hematology-Oncology | Hematopoietic stem cell transplantation | Indications | – | Categories of Stem Cell Transplantation |
Hematology-Oncology | Hematopoietic stem cell transplantation | Transplantation procedure | – | Prophylaxis and Supportive Medications during HSCT |
Hematology-Oncology | Hematopoietic stem cell transplantation | Complications | – | Timing of Complications following Allogeneic HSCT |
Hematology-Oncology | Lung cancer | Pathology and Genetics of Lung Cancer | – | Pathology and Genetics of Lung Cancer |
Hematology-Oncology | Lung cancer | Epidemiology and risk factors | – | – |
Hematology-Oncology | Lung cancer | Clinical manifestations | – | – |
Hematology-Oncology | Lung cancer | Screening | – | – |
Hematology-Oncology | Lung cancer | Diagnostic and staging evaluation | – | TNM Staging System for NSCLC |
Hematology-Oncology | Lung cancer | NSCLC Treatment | – | NSCLC Simplified Staging Schema |
Hematology-Oncology | Lung cancer | SCLC Treatment | – | – |
Hematology-Oncology | Breast cancer | Epidemiology and genetics | – | – |
Hematology-Oncology | Breast cancer | Clinical manifestations | – | – |
Hematology-Oncology | Breast cancer | Screening | – | – |
Hematology-Oncology | Breast cancer | Diagnostic evaluation | – | – |
Hematology-Oncology | Breast cancer | Staging | – | Simplified Staging System for Breast Cancer |
Hematology-Oncology | Breast cancer | Treatment | – | Treatment of Carcinoma in situ and Invasive Carcinoma of the Breast |
Hematology-Oncology | Breast cancer | Prevention | – | – |
Hematology-Oncology | Prostate cancer | Epidemiology and risk factors | – | – |
Hematology-Oncology | Prostate cancer | Clinical manifestations | – | – |
Hematology-Oncology | Prostate cancer | Screening | – | – |
Hematology-Oncology | Prostate cancer | Diagnostic and staging evaluation | – | TNM Staging and Treatment of Prostate Cancer |
Hematology-Oncology | Prostate cancer | Prognosis | – | – |
Hematology-Oncology | Prostate cancer | Prevention | – | – |
Hematology-Oncology | Colorectal cancer | Epidemiology and risk factors | – | – |
Hematology-Oncology | Colorectal cancer | Pathology and genetics | – | – |
Hematology-Oncology | Colorectal cancer | Clinical manifestations | – | – |
Hematology-Oncology | Colorectal cancer | Screening | – | – |
Hematology-Oncology | Colorectal cancer | Staging | – | Treatment Based on TNM and Modified Dukes Staging of Colorectal Cancer |
Hematology-Oncology | Chemotherapy side effects | Chemotherapy Side Effects | – | Select Adverse Effects from Chemotherapy |
Hematology-Oncology | Pancreatic tumors | Pathology and genetics | – | – |
Hematology-Oncology | Pancreatic tumors | Epidemiology and risk factors | – | – |
Hematology-Oncology | Pancreatic tumors | Clinical manifestations | – | – |
Hematology-Oncology | Pancreatic tumors | Diagnostic and staging evaluation | – | Staging and Prognosis of Pancreatic Adenocarcinoma |
Hematology-Oncology | Pancreatic tumors | Treatment of pancreatic adenocarcinoma | – | – |
Hematology-Oncology | Pancreatic tumors | Cystic lesions of the pancreas | – | – |
Hematology-Oncology | Fever and neutropenia | Definition | – | – |
Hematology-Oncology | Fever and neutropenia | Pathophysiology and microbiology | – | – |
Hematology-Oncology | Fever and neutropenia | Prevention | – | – |
Hematology-Oncology | Fever and neutropenia | Diagnostic evaluation | – | – |
Hematology-Oncology | Fever and neutropenia | Risk stratification | – | – |
Hematology-Oncology | Fever and neutropenia | Initial antibiotic therapy | – | – |
Hematology-Oncology | Fever and neutropenia | Modification to initial antibiotic regimen | – | – |
Hematology-Oncology | Fever and neutropenia | Duration of therapy | – | – |
Hematology-Oncology | Fever and neutropenia | Role of hematopoietic growth factors | – | – |
Hematology-Oncology | Spinal cord compression | Clinical manifestations | – | – |
Hematology-Oncology | Spinal cord compression | Diagnostic evaluation | – | – |
Hematology-Oncology | Spinal cord compression | Treatment | – | – |
Hematology-Oncology | Tumor lysis syndrome | Clinical manifestations | – | – |
Hematology-Oncology | Tumor lysis syndrome | Prophylaxis | – | – |
Hematology-Oncology | Tumor lysis syndrome | Treatment | – | – |
Hematology-Oncology | Cancer of unknown primary site | Cancer of Unknown Primary Site | – | Evaluation of Cancer of Unknown Primary Site |
Infectious Diseases | Pneumonia | Microbiology of Pneumonia | – | Microbiology of Pneumonia |
Infectious Diseases | Pneumonia | Clinical manifestations | – | – |
Infectious Diseases | Pneumonia | Diagnostic studies | – | – |
Infectious Diseases | Pneumonia | Prognosis | – | – |
Infectious Diseases | Pneumonia | Treatment | – | Treatment of Pneumonia |
Infectious Diseases | Pneumonia | Prevention | – | – |
Infectious Diseases | Viral respiratory infections | Microbiology & epidemiology | – | – |
Infectious Diseases | Viral respiratory infections | Diagnosis | – | – |
Infectious Diseases | Viral respiratory infections | Treatment | – | – |
Infectious Diseases | Viral respiratory infections | Prevention | – | – |
Infectious Diseases | Fungal infections | Candida species | – | Treatment of Candidiasis |
Infectious Diseases | Fungal infections | Cryptococcus | – | – |
Infectious Diseases | Fungal infections | Histoplasmosis | – | – |
Infectious Diseases | Fungal infections | Coccidioidomycosis | – | – |
Infectious Diseases | Fungal infections | Blastomycosis | – | – |
Infectious Diseases | Fungal infections | Aspergillosis | – | – |
Infectious Diseases | Fungal infections | Zygomycetes | – | – |
Infectious Diseases | Fungal infections | Fungal diagnostics | – | – |
Infectious Diseases | Infections in immunocompromised hosts | Classic Infectious Etiologies in Immunocompromised Hosts | – | Classic Infectious Etiologies in Immunocompromised Hosts |
Infectious Diseases | Urinary tract infection | Definitions | – | – |
Infectious Diseases | Urinary tract infection | Microbiology | – | – |
Infectious Diseases | Urinary tract infection | Clinical manifestations | – | – |
Infectious Diseases | Urinary tract infection | Diagnostic studies | – | – |
Infectious Diseases | Urinary tract infection | Treatment | – | Treatment of UTI |
Infectious Diseases | Cellulitis | Microbiology & clinical | – | – |
Infectious Diseases | Cellulitis | Diagnosis | – | Microbiology of Bite Infections |
Infectious Diseases | Cellulitis | Treatment | – | Treatment of Cellulitis |
Infectious Diseases | Other cutaneous infections | Other Cutaneous Infections | – | Other Cutaneous Infections |
Infectious Diseases | Diabetic foot | Microbiology | – | – |
Infectious Diseases | Diabetic foot | Clinical manifestations | – | – |
Infectious Diseases | Diabetic foot | Diagnostic studies | – | – |
Infectious Diseases | Diabetic foot | Treatment | – | Treatment of Diabetic Foot |
Infectious Diseases | Necrotizing fasciitis | Definition | – | – |
Infectious Diseases | Necrotizing fasciitis | Epidemiology | – | – |
Infectious Diseases | Necrotizing fasciitis | Microbiology | – | – |
Infectious Diseases | Necrotizing fasciitis | Clinical manifestations | – | – |
Infectious Diseases | Necrotizing fasciitis | Diagnostic signs | – | – |
Infectious Diseases | Necrotizing fasciitis | Treatment | – | – |
Infectious Diseases | Necrotizing fasciitis | Prognosis | – | – |
Infectious Diseases | Clostridial myonecrosis | Definition | – | – |
Infectious Diseases | Clostridial myonecrosis | Clinical manifestations | – | – |
Infectious Diseases | Clostridial myonecrosis | Diagnostic signs | – | – |
Infectious Diseases | Clostridial myonecrosis | Treatment | – | – |
Infectious Diseases | Osteomyelitis | Microbiology | – | – |
Infectious Diseases | Osteomyelitis | Clinical manifestations | – | – |
Infectious Diseases | Osteomyelitis | Diagnostic studies | – | – |
Infectious Diseases | Osteomyelitis | Treatment | – | – |
Infectious Diseases | Epidural abscess | Etiology | – | – |
Infectious Diseases | Epidural abscess | Clinical manifestations | – | – |
Infectious Diseases | Epidural abscess | Diagnostic studies | – | – |
Infectious Diseases | Epidural abscess | Treatment | – | – |
Infectious Diseases | Acute bacterial meningitis | Definition | – | Microbiology in Adult Meningitis |
Infectious Diseases | Acute bacterial meningitis | Clinical manifestations | – | – |
Infectious Diseases | Acute bacterial meningitis | Physical exam | – | – |
Infectious Diseases | Acute bacterial meningitis | Diagnostic studies | – | – |
Infectious Diseases | Acute bacterial meningitis | Recurrent meningitis | – | Typical CSF Findings in Meningitis |
Infectious Diseases | Acute bacterial meningitis | Treatment | – | Treatment of Meningitis |
Infectious Diseases | Acute bacterial meningitis | Prognosis | – | – |
Infectious Diseases | Aseptic meningitis | Definition | – | – |
Infectious Diseases | Aseptic meningitis | Etiologies | – | – |
Infectious Diseases | Aseptic meningitis | Empiric treatment | – | – |
Infectious Diseases | Encephalitis | Definition | – | – |
Infectious Diseases | Encephalitis | Etiologies | – | – |
Infectious Diseases | Encephalitis | Clinical manifestations | – | – |
Infectious Diseases | Encephalitis | Diagnostic studies | – | – |
Infectious Diseases | Encephalitis | Treatment | – | – |
Infectious Diseases | Bell's palsy | Definition & etiologies | – | – |
Infectious Diseases | Bell's palsy | Clinical manifestations | – | – |
Infectious Diseases | Bell's palsy | Diagnosis | – | – |
Infectious Diseases | Bell's palsy | Treatment | – | – |
Infectious Diseases | Zoster | Definition & etiology | – | – |
Infectious Diseases | Zoster | Clinical manifestations | – | – |
Infectious Diseases | Zoster | Diagnosis | – | – |
Infectious Diseases | Zoster | Treatment | – | – |
Infectious Diseases | Bacterial endocarditis | Definition | – | Microbiology of Endocarditis |
Infectious Diseases | Bacterial endocarditis | Predisposing conditions | – | Modified Duke Criteria for Endocarditis |
Infectious Diseases | Bacterial endocarditis | Clinical manifestations | – | – |
Infectious Diseases | Bacterial endocarditis | Physical exam | – | – |
Infectious Diseases | Bacterial endocarditis | Diagnostic studies | – | – |
Infectious Diseases | Bacterial endocarditis | Treatment | – | – |
Infectious Diseases | Bacterial endocarditis | Indications for surgery | – | – |
Infectious Diseases | Bacterial endocarditis | Prognosis | – | Endocarditis prophylaxis |
Infectious Diseases | Bacteremia | Etiologies | – | – |
Infectious Diseases | Bacteremia | Microbiology | – | – |
Infectious Diseases | Bacteremia | Risk factors for true bacteremia | – | – |
Infectious Diseases | Bacteremia | Diagnosis | – | – |
Infectious Diseases | Bacteremia | Treatment | – | – |
Infectious Diseases | Tuberculosis | Epidemiology | – | – |
Infectious Diseases | Tuberculosis | Microbiology & natural history | – | – |
Infectious Diseases | Tuberculosis | Screening for prior infection | – | – |
Infectious Diseases | Tuberculosis | Clinical manifestations | – | – |
Infectious Diseases | Tuberculosis | Diagnostic studies for active TB | – | – |
Infectious Diseases | Tuberculosis | Preventive therapy | – | Prophylactic Regimen for TB |
Infectious Diseases | Tuberculosis | Treatment of active tuberculosis | – | Antituberculous Medications |
Infectious Diseases | Tuberculosis | Antituberculous Treatment Regimens | – | Antituberculous Treatment Regimens |
Infectious Diseases | Hiv/aids | Definition | – | – |
Infectious Diseases | Hiv/aids | Epidemiology | – | – |
Infectious Diseases | Hiv/aids | Acute retroviral syndrome | – | – |
Infectious Diseases | Hiv/aids | Diagnostic studies | – | – |
Infectious Diseases | Hiv/aids | Approach to newly diagnosed HIV pt | – | Antiretrovirals and Side Effects |
Infectious Diseases | Hiv/aids | Approach to previously established HIV pt | – | – |
Infectious Diseases | Hiv/aids | Opportunistic infection prophylaxis | – | Opportunistic infection prophylaxis |
Infectious Diseases | Complications of hiv/aids | Fever | – | – |
Infectious Diseases | Complications of hiv/aids | Cutaneous | – | – |
Infectious Diseases | Complications of hiv/aids | Ophthalmologic | – | – |
Infectious Diseases | Complications of hiv/aids | Oral | – | – |
Infectious Diseases | Complications of hiv/aids | Endocrine/metabolic | – | – |
Infectious Diseases | Complications of hiv/aids | Cardiac | – | – |
Infectious Diseases | Complications of hiv/aids | Pulmonary | – | – |
Infectious Diseases | Complications of hiv/aids | Gastrointestinal & hepatobiliary | – | – |
Infectious Diseases | Complications of hiv/aids | Renal | – | – |
Infectious Diseases | Complications of hiv/aids | Hematologic/oncologic | – | – |
Infectious Diseases | Complications of hiv/aids | Neurologic | – | – |
Infectious Diseases | Complications of hiv/aids | Disseminated Mycobacterium avium complex | – | – |
Infectious Diseases | Complications of hiv/aids | Cytomegalovirus | – | – |
Infectious Diseases | Tick-borne illness | Distinguishing features of tick-borne illnesses | – | Distinguishing features of tick-borne illnesses |
Infectious Diseases | Lyme disease | Microbiology | – | – |
Infectious Diseases | Lyme disease | Epidemiology | – | – |
Infectious Diseases | Lyme disease | Diagnostic studies | – | – |
Infectious Diseases | Lyme disease | Treatment | – | – |
Infectious Diseases | Rocky mountain spotted fever | Microbiology & epidemiology | – | – |
Infectious Diseases | Rocky mountain spotted fever | Clinical manifestations | – | – |
Infectious Diseases | Rocky mountain spotted fever | Diagnosis | – | – |
Infectious Diseases | Rocky mountain spotted fever | Treatment | – | – |
Infectious Diseases | Ehrlichiosis/anaplasmosis | Microbiology | – | – |
Infectious Diseases | Ehrlichiosis/anaplasmosis | Epidemiology | – | – |
Infectious Diseases | Ehrlichiosis/anaplasmosis | Clinical manifestations | – | – |
Infectious Diseases | Ehrlichiosis/anaplasmosis | Diagnosis | – | – |
Infectious Diseases | Ehrlichiosis/anaplasmosis | Treatment | – | – |
Infectious Diseases | Babesiosis | Microbiology & epidemiology | – | – |
Infectious Diseases | Babesiosis | Clinical manifestations | – | – |
Infectious Diseases | Babesiosis | Diagnosis | – | – |
Infectious Diseases | Babesiosis | Treatment | – | – |
Infectious Diseases | Tularemia | Microbiology | – | – |
Infectious Diseases | Tularemia | Clinical manifestations | – | – |
Infectious Diseases | Tularemia | Diagnosis & treatment | – | – |
Infectious Diseases | Fever syndromes | Diagnosis approach | – | – |
Infectious Diseases | Fever of unknown origin | Definition & etiologies | – | Etiologies of Classic FUO |
Infectious Diseases | Fever of unknown origin | Workup | – | – |
Infectious Diseases | Fever of unknown origin | Treatment | – | – |
Infectious Diseases | Fever and rash | Approach to diagnostic workup | – | Possible Etiology |
Infectious Diseases | Fever and rash | Treatment | – | – |
Infectious Diseases | Fever in a returned traveler | Definition & etiologies | – | Common Etiologies of Fever in A Returned Traveler |
Infectious Diseases | Fever in a returned traveler | Select clinical manifestations | – | – |
Infectious Diseases | Fever in a returned traveler | Workup | – | – |
Endocrinology | Hypopituitary syndromes | Panhypopituitarism | – | – |
Endocrinology | Hyperpituitary syndromes | Pituitary tumors | – | – |
Endocrinology | Hyperpituitary syndromes | Hyperprolactinemia | – | – |
Endocrinology | Hyperpituitary syndromes | Acromegaly | – | – |
Endocrinology | Hyperpituitary syndromes | Cushing's disease | – | – |
Endocrinology | Hyperpituitary syndromes | Central hyperthyroidism | – | – |
Endocrinology | Hyperpituitary syndromes | Multiple Endocrine Neoplasia Syndromes | – | Multiple Endocrine Neoplasia Syndromes |
Endocrinology | Hyperpituitary syndromes | Polyglandular Autoimmune Syndromes | – | Polyglandular Autoimmune Syndromes |
Endocrinology | Thyroid disorders | Diagnostic Studies in Thyroid Disorders | – | Diagnostic Studies in Thyroid Disorders |
Endocrinology | Thyroid disorders | Approach to Thyroid Disorders | Approach to Thyroid Disorders | – |
Endocrinology | Hypothyroidism | Etiologies | – | – |
Endocrinology | Hypothyroidism | Hashimoto's thyroiditis | – | – |
Endocrinology | Hypothyroidism | Clinical manifestations | – | – |
Endocrinology | Hypothyroidism | Diagnostic studies | – | – |
Endocrinology | Hypothyroidism | Treatment of overt hypothyroidism | – | – |
Endocrinology | Hypothyroidism | Subclinical hypothyroidism | – | – |
Endocrinology | Hyperthyroidism | Etiologies | – | – |
Endocrinology | Hyperthyroidism | Clinical manifestations of hyperthyroidism | – | – |
Endocrinology | Hyperthyroidism | Laboratory testing | – | – |
Endocrinology | Hyperthyroidism | Graves' disease | – | – |
Endocrinology | Hyperthyroidism | Thyroiditis | – | – |
Endocrinology | Hyperthyroidism | Treatment | – | – |
Endocrinology | Hyperthyroidism | Subclinical hyperthyroidism | – | – |
Endocrinology | Nonthyroidal illness | Sick euthyroid syndrome | – | – |
Endocrinology | Amiodarone and thyroid disease | Amiodarone-induced hypothyroidism | – | – |
Endocrinology | Amiodarone and thyroid disease | Amiodarone-induced hyperthyroidism | – | – |
Endocrinology | Thyroid nodules | Approach to thyroid nodules | Approach to thyroid nodules | – |
Endocrinology | Cushing's syndrome | Definitions | – | – |
Endocrinology | Cushing's syndrome | Etiologies of hypercortisolism | – | – |
Endocrinology | Cushing's syndrome | Clinical manifestations | Approach to suspected Cushing's syndrome | – |
Endocrinology | Cushing's syndrome | Treatment of Cushing's syndrome | – | – |
Endocrinology | Hyperaldosteronism | Etiologies | – | – |
Endocrinology | Hyperaldosteronism | Clinical manifestations | – | – |
Endocrinology | Hyperaldosteronism | Diagnostic studies | Approach to suspected hyperaldosteronism | – |
Endocrinology | Hyperaldosteronism | Treatment | – | – |
Endocrinology | Adrenal insufficiency | Etiologies | – | – |
Endocrinology | Adrenal insufficiency | Clinical manfiestations | – | – |
Endocrinology | Adrenal insufficiency | Diagnostic studies | – | – |
Endocrinology | Adrenal insufficiency | Adrenal insufficiency & critical illness | – | – |
Endocrinology | Adrenal insufficiency | Treatment | – | – |
Endocrinology | Pheochromocytoma | Clinical manifestations | – | – |
Endocrinology | Pheochromocytoma | Diagnostic studies | – | – |
Endocrinology | Pheochromocytoma | Treatment | – | – |
Endocrinology | Adrenal incidentalomas | Epidemiology | – | – |
Endocrinology | Adrenal incidentalomas | Differential diagnosis | – | – |
Endocrinology | Adrenal incidentalomas | Workup | – | – |
Endocrinology | Calcium disorders | Pitfalls in measuring calcium | – | Laboratory Findings in Calcium Disorders |
Endocrinology | Hypercalcemia | Clinical manifestations | – | Etiologies of Hypercalcemia |
Endocrinology | Hypercalcemia | Diagnostic studies | – | – |
Endocrinology | Hypercalcemia | Treatment | – | Treatment of Hypercalcemia |
Endocrinology | Hypercalcemia | Treatment of asymptomatic primary HPT | – | – |
Endocrinology | Hypocalcemia | Clinical manifestations | – | Etiologies of Hypocalcemia |
Endocrinology | Hypocalcemia | Diagnostic studies | – | – |
Endocrinology | Hypocalcemia | Treatment | – | – |
Endocrinology | Diabetes mellitus | Definition | – | – |
Endocrinology | Diabetes mellitus | Categories | – | – |
Endocrinology | Diabetes mellitus | Clinical manifestations | – | – |
Endocrinology | Diabetes mellitus | Treatment | – | Diabetes Treatment Options |
Endocrinology | Diabetes mellitus | Insulin Preparations | – | Insulin Preparations |
Endocrinology | Diabetes mellitus | Complications | – | – |
Endocrinology | Diabetes mellitus | Outpatient screening and treatment goals | – | – |
Endocrinology | Diabetes mellitus | Management of hyperglycemia in inpatients | – | – |
Endocrinology | Diabetic ketoacidosis | Precipitants | – | – |
Endocrinology | Diabetic ketoacidosis | Pathophysiology | – | – |
Endocrinology | Diabetic ketoacidosis | Clinical manifestations | – | – |
Endocrinology | Diabetic ketoacidosis | Diagnostic studies | – | Typical DKA Flow Sheet Setup |
Endocrinology | Diabetic ketoacidosis | Treatment | – | Treatment of DKA |
Endocrinology | Hyperosmolar hyperglycemic state | Definition, precipitants, pathophysiology | – | – |
Endocrinology | Hyperosmolar hyperglycemic state | Clinical manifestations & dx studies | – | – |
Endocrinology | Hyperosmolar hyperglycemic state | Treatment | – | – |
Endocrinology | Hypoglycemia | Clinical manifestations | – | – |
Endocrinology | Hypoglycemia | Etiologies in diabetics | – | – |
Endocrinology | Hypoglycemia | Etiologies in nondiabetics | – | – |
Endocrinology | Hypoglycemia | Evaluation in nondiabetics | – | – |
Endocrinology | Hypoglycemia | Treatment | – | – |
Endocrinology | Lipid disorders | Measurements | – | – |
Endocrinology | Lipid disorders | Primary dyslipidemia | – | – |
Endocrinology | Lipid disorders | Secondary dyslipidemia | – | Secondary dyslipidemia |
Endocrinology | Lipid disorders | Physical exam findings | – | – |
Endocrinology | Lipid disorders | Treatment | – | NCEP Guidelines of Dyslipidemia |
Endocrinology | Lipid disorders | Drug treatment | – | Drug Treatment of Dyslipidemia |
Rheumatology | Arthritis | Approach to patients with joint pain | – | Key Physical Exam Findings in Joint Pain |
Rheumatology | Arthritis | Approach to arthritis | Approach to arthritis | – |
Rheumatology | Arthritis | Analysis of joint fluid | – | Analysis of Joint Fluid |
Rheumatology | Arthritis | Comparison of major arthritides | – | Comparison of Major Arthritides |
Rheumatology | Arthritis | Radiologic features | – | – |
Rheumatology | Inflammatory markers & autoantibody testing | Inflammatory Markers | – | – |
Rheumatology | Inflammatory markers & autoantibody testing | Autoantibody Testing | – | – |
Rheumatology | Rheumatoid arthritis | Definition & epidemiology | – | – |
Rheumatology | Rheumatoid arthritis | Clinical manifestations | – | Extra-Articular Manifestations of RA |
Rheumatology | Rheumatoid arthritis | Laboratory & radiologic studies | – | – |
Rheumatology | Rheumatoid arthritis | ACR/EULAR classification criteria of RA | – | ACR/EULAR classification criteria of RA |
Rheumatology | Rheumatoid arthritis | Management | – | RA Therapeutics |
Rheumatology | Adult onset still’s disease & relapsing polychondritis | Adult Onset Still’s Disease | – | – |
Rheumatology | Adult onset still’s disease & relapsing polychondritis | Relapsing Polychondritis | – | – |
Rheumatology | Gout | Definition & epidemiology | – | – |
Rheumatology | Gout | Clinical manifestations | – | – |
Rheumatology | Gout | Diagnostic studies | – | – |
Rheumatology | Gout | Acute treatment | – | Acute Treatment of Gout |
Rheumatology | Gout | Chronic treatment | – | Urate Lowering Therapy |
Rheumatology | Calcium pyrophosphate dihydrate deposition disease | Definition | – | – |
Rheumatology | Calcium pyrophosphate dihydrate deposition disease | Etiologies | – | – |
Rheumatology | Calcium pyrophosphate dihydrate deposition disease | Clinical manifestations | – | – |
Rheumatology | Calcium pyrophosphate dihydrate deposition disease | Diagnostic studies | – | – |
Rheumatology | Calcium pyrophosphate dihydrate deposition disease | Treatment | – | – |
Rheumatology | Seronegative spondyloarthritis | Classification system | – | – |
Rheumatology | Seronegative spondyloarthritis | Epidemiology & pathogenesis | – | SpA Epidemiology and Features |
Rheumatology | Seronegative spondyloarthritis | Major clinical manifestations | – | SpA Distinguishing Features |
Rheumatology | Seronegative spondyloarthritis | Descriptions of skin manifestations | – | – |
Rheumatology | Seronegative spondyloarthritis | Clinical assessment | – | – |
Rheumatology | Seronegative spondyloarthritis | Treatment approach | – | – |
Rheumatology | Infectious arthritis | Etiologies | – | – |
Rheumatology | Infectious arthritis | Diagnosis | – | – |
Rheumatology | Bacterial arthritis | Epidemiology & risk factors | – | – |
Rheumatology | Bacterial arthritis | Clinical manifestations | – | – |
Rheumatology | Bacterial arthritis | Additional diagnostic studies | – | – |
Rheumatology | Bacterial arthritis | Treatment | – | Treatment of Bacterial Arthritis |
Rheumatology | Bacterial arthritis | Prosthetic joint infections | – | – |
Rheumatology | Disseminated gonococcal infection | Epidemiology | – | – |
Rheumatology | Disseminated gonococcal infection | Clinical manifestations | – | – |
Rheumatology | Disseminated gonococcal infection | Additional diagnostic studies | – | – |
Rheumatology | Disseminated gonococcal infection | Treatment | – | – |
Rheumatology | Olecranon and prepatellar bursitis | Epidemiology & risk factors | – | – |
Rheumatology | Olecranon and prepatellar bursitis | Diagnosis | – | – |
Rheumatology | Olecranon and prepatellar bursitis | Initial therapy | – | – |
Rheumatology | Connective tissue diseases | Autoantibodies in Patients with Rheumatic Diseases | – | Autoantibodies in Patients with Rheumatic Diseases |
Rheumatology | Systemic sclerosis and scleroderma | Definition & epidemiology | – | – |
Rheumatology | Systemic sclerosis and scleroderma | Classification criteria | – | – |
Rheumatology | Systemic sclerosis and scleroderma | Diagnostic studies & monitoring | – | Clinical Manifestations of Systemic Sclerosis |
Rheumatology | Systemic sclerosis and scleroderma | Systemic Sclerosis Subgroup Comparison | – | SSc Subgroup Comparison |
Rheumatology | Systemic sclerosis and scleroderma | Treatment | – | – |
Rheumatology | Inflammatory myopathies | Definition & epidemiology | – | – |
Rheumatology | Inflammatory myopathies | Clinical manifestations | – | – |
Rheumatology | Inflammatory myopathies | Diagnostic studies | – | Differential Diagnosis of Myositides, Myopathies, and Myalgias |
Rheumatology | Inflammatory myopathies | Treatment | – | – |
Rheumatology | Sjogren's syndrome | Definition & epidemiology | – | – |
Rheumatology | Sjogren's syndrome | Clinical manifestations | – | – |
Rheumatology | Sjogren's syndrome | Diagnostic studies | – | – |
Rheumatology | Sjogren's syndrome | Treatment | – | – |
Rheumatology | Mixed connective tissue disease | Definition | – | – |
Rheumatology | Mixed connective tissue disease | Clinical manifestations | – | – |
Rheumatology | Mixed connective tissue disease | Diagnostic studies | – | – |
Rheumatology | Mixed connective tissue disease | Treatment | – | – |
Rheumatology | Raynaud's phenomenon | Clinical manifestations | – | – |
Rheumatology | Raynaud's phenomenon | Primary Raynaud's phenomenon | – | – |
Rheumatology | Raynaud's phenomenon | Secondary Raynaud's phenomenon | – | – |
Rheumatology | Raynaud's phenomenon | Treatment | – | – |
Rheumatology | Systemic lupus erythematosus | Epidemiology | – | Classification Criteria and Clinical Manifestations of SLE |
Rheumatology | Systemic lupus erythematosus | Workup | – | Autoantibodies in SLE |
Rheumatology | Systemic lupus erythematosus | Treatment | – | Treatment of SLE |
Rheumatology | Systemic lupus erythematosus | Lupus nephritis | – | Lupus nephritis |
Rheumatology | Systemic lupus erythematosus | Prognosis | – | – |
Rheumatology | Systemic lupus erythematosus | Drug-induced lupus | – | – |
Rheumatology | Vasculitis | Distinguishing Characteristics of Vasculitis Subtypes | – | Distinguishing Characteristics of Vasculitis Subtypes |
Rheumatology | Large-vessel vasculitis | Takayasu's arteritis | – | – |
Rheumatology | Large-vessel vasculitis | Giant cell arteritis | – | – |
Rheumatology | Medium-vessel vasculitis | Polyarteritis nodosa | – | – |
Rheumatology | Anca-associated small-vessel vasculitis | Differential Diagnosis of ANCA | – | Differential Diagnosis of ANCA |
Rheumatology | Anca-associated small-vessel vasculitis | Granulomatosis with polyangiitis | – | – |
Rheumatology | Anca-associated small-vessel vasculitis | Microscopic polyangiitis | – | – |
Rheumatology | Anca-associated small-vessel vasculitis | Eosinophilic granulomatosis with polyangiitis | – | – |
Rheumatology | Anca-associated small-vessel vasculitis | Renal-limited vasculitis | – | – |
Rheumatology | Immune complex-associated small-vessel vasculitis | Henoch-Schonlein purpura | – | – |
Rheumatology | Immune complex-associated small-vessel vasculitis | Cryoglobulinemic vasculitis | – | – |
Rheumatology | Immune complex-associated small-vessel vasculitis | Connective tissue disease-associated vasculitis | – | – |
Rheumatology | Immune complex-associated small-vessel vasculitis | Cutaneous leukocytoclastic angiitis | – | – |
Rheumatology | Immune complex-associated small-vessel vasculitis | Behcet's syndrome | – | – |
Rheumatology | Igg4-related disease | Definition & etiology | – | – |
Rheumatology | Igg4-related disease | Clinical manifestations | – | – |
Rheumatology | Igg4-related disease | Diagnosis | – | – |
Rheumatology | Igg4-related disease | Treatment | – | – |
Rheumatology | Cryoglobulinemia | Definition & types | – | – |
Rheumatology | Cryoglobulinemia | Etiologies | – | – |
Rheumatology | Cryoglobulinemia | Pathophysiology | – | – |
Rheumatology | Cryoglobulinemia | Clinical manifestations | – | – |
Rheumatology | Cryoglobulinemia | Diagnostic studies | – | – |
Rheumatology | Cryoglobulinemia | Treatment | – | – |
Rheumatology | Amyloidosis | Classification | – | Classification of Amyloidosis |
Rheumatology | Amyloidosis | Clinical manifestations | – | Clinical Manifestations of Amyloidosis |
Rheumatology | Amyloidosis | Diagnostic studies | – | – |
Rheumatology | Amyloidosis | Treatment | – | – |
Rheumatology | Amyloidosis | Prognosis | – | – |
Neurology | Change in mental status | Definitions | – | – |
Neurology | Change in mental status | Initial evaluation | – | Etiologies of Altered Mental Status |
Neurology | Change in mental status | Neuro Exam of Altered Mental Status | – | Neuro Exam of Altered Mental Status |
Neurology | Change in mental status | Glasgow Coma Scale | – | Glasgow Coma Scale |
Neurology | Change in mental status | Initial treatment | – | – |
Neurology | Change in mental status | Diagnostic studies | – | – |
Neurology | Change in mental status | Further treatment of delirium | – | – |
Neurology | Anoxic brain injury | Prevalence | – | – |
Neurology | Anoxic brain injury | Initial evaluation | – | – |
Neurology | Anoxic brain injury | Induced hypothermia | – | – |
Neurology | Anoxic brain injury | Ongoing evaluation | – | – |
Neurology | Anoxic brain injury | Prognosis | – | – |
Neurology | Seizures | Definitions | – | – |
Neurology | Seizures | Differential diagnosis | – | Seizure vs Syncope |
Neurology | Seizures | Etiologies | – | – |
Neurology | Seizures | Clinical manifestations | – | – |
Neurology | Seizures | Clinical evaluation | – | – |
Neurology | Seizures | Diagnostic studies | – | – |
Neurology | Seizures | Treatment | – | Antiepileptic Drugs and Side Effects |
Neurology | Seizures | Status epilepticus | – | Treatment of Status Epilepticus |
Neurology | Alcohol withdrawal | Pathophysiology | – | – |
Neurology | Alcohol withdrawal | Clinical manifestations | – | – |
Neurology | Alcohol withdrawal | Clinical Institute Withdrawal Assessment scale for Alcohol | – | CIWA-Ar Scale |
Neurology | Alcohol withdrawal | Treatment | – | – |
Neurology | Ischemic stroke | Etiologies | – | – |
Neurology | Ischemic stroke | Clinical manifestations | – | Stroke Syndromes by Vascular Territory |
Neurology | Ischemic stroke | Transient ischemic attack | – | – |
Neurology | Ischemic stroke | Physical exam | – | – |
Neurology | Ischemic stroke | Acute workup | – | – |
Neurology | Ischemic stroke | Workup to assess for etiology/modifiable risk factors | – | – |
Neurology | Ischemic stroke | Acute treatment of ischemic stroke | – | – |
Neurology | Ischemic stroke | Secondary stroke prevention | – | – |
Neurology | Ischemic stroke | Patent foramen ovale | – | – |
Neurology | Intracranial hemorrhage | Classification by location | – | – |
Neurology | Intracranial hemorrhage | Etiologies | – | – |
Neurology | Intracranial hemorrhage | Clinical manifestations | – | – |
Neurology | Intracranial hemorrhage | Workup | – | – |
Neurology | Intracranial hemorrhage | Management | – | – |
Neurology | Weakness & neuromuscular dysfunction | Weakness & Neuromuscular Dysfunction | – | Weakness & Neuromuscular Dysfunction |
Neurology | Peripheral neuropathies | Etiologies | – | – |
Neurology | Peripheral neuropathies | Clinical manifestations | – | – |
Neurology | Peripheral neuropathies | Diagnostic studies | – | – |
Neurology | Peripheral neuropathies | Treatment of neuropathic pain | – | – |
Neurology | Guillain-barre syndrome | Definition & epidemiology | – | – |
Neurology | Guillain-barre syndrome | Clinical manifestations | – | – |
Neurology | Guillain-barre syndrome | Diagnostic studies | – | – |
Neurology | Guillain-barre syndrome | Treatment | – | – |
Neurology | Myasthenia gravis | Definition & epidemiology | – | – |
Neurology | Myasthenia gravis | Clinical manifestations | – | – |
Neurology | Myasthenia gravis | Diagnostic studies | – | – |
Neurology | Myasthenia gravis | Treatment | – | – |
Neurology | Myopathies | Definition & epidemiology | – | – |
Neurology | Myopathies | Clinical manifestations | – | – |
Neurology | Myopathies | Diagnostic studies | – | – |
Neurology | Headache | Primary headache syndromes | – | – |
Neurology | Headache | Secondary causes of headache | – | – |
Neurology | Headache | Clinical evaluation | – | – |
Neurology | Migraine | Epidemiology | – | – |
Neurology | Migraine | Definition & clinical manifestations | – | – |
Neurology | Migraine | Treatment | – | – |
Neurology | Back and spinal cord disease | Differential diagnosis of back pain | – | – |
Neurology | Back and spinal cord disease | Initial evaluation | – | – |
Neurology | Spinal cord compression | Clinical manifestations | – | – |
Neurology | Spinal cord compression | Evaluation & treatment | – | Conus Medullaris vs Cauda Equina Syndromes |
Neurology | Nerve root compression | Clinical manifestations | – | Cervical and Lumbar Radiculopathy |
Neurology | Nerve root compression | Neurogenic vs Vascular Claudication | – | Neurogenic vs Vascular Claudication |
Neurology | Nerve root compression | Treatment of nerve root compression | – | – |
Surgical Issues | Abdominal pain | Viscera and Area to which pain referred | – | Viscera and Area to which pain referred |
Surgical Issues | Abdominal pain | Etiologies of Abdominal Pain by Location | Etiologies of Abdominal Pain by Location | – |
Surgical Issues | Abdominal pain | Inital evaluation | – | – |
Surgical Issues | Acute abdomen | Definition | – | – |
Surgical Issues | Acute abdomen | Etiologies | – | – |
Surgical Issues | Acute abdomen | Inital evaluation | – | – |
Surgical Issues | Acute abdomen | Initial management | – | – |
Surgical Issues | Extremity emergencies | Acute limb ischemia | – | – |
Surgical Issues | Extremity emergencies | Compartment syndrome | – | – |
Surgical Issues | Surgical tubes, drains, and wounds | Tracheostomy | – | – |
Surgical Issues | Surgical tubes, drains, and wounds | Chest tubes | – | – |
Surgical Issues | Surgical tubes, drains, and wounds | Gastrostomy/jejunostomy tubes | – | – |
Surgical Issues | Surgical tubes, drains, and wounds | Suture/staple removal | – | – |
Ob/Gyn Issues | Vaginal bleeding | Etiologies | – | – |
Ob/Gyn Issues | Vaginal bleeding | History & exam | – | – |
Ob/Gyn Issues | Vaginal bleeding | Laboratory evaluation & imaging | – | – |
Ob/Gyn Issues | Vaginal discharge | Etiologies | – | – |
Ob/Gyn Issues | Vaginal discharge | Initial evaluation | – | – |
Ob/Gyn Issues | Vaginal discharge | Treatment | – | – |
Ob/Gyn Issues | Adnexal mass in non-pregnant woman | Etiologies | – | – |
Ob/Gyn Issues | Adnexal mass in non-pregnant woman | Initial evaluation | – | – |
Ophthalmic Issues | Acute visual changes | Etiologies of Acute Vision Loss | – | Etiologies of Acute Vision Loss |
Ophthalmic Issues | Acute visual changes | Descriptions & etiologies of other visual changes | – | – |
Ophthalmic Issues | Red eye | Common Etiologies of Red Eye | – | Common Etiologies of Red Eye |
Ophthalmic Issues | Other conditions | Optic Nerve Disorders | – | – |
Ophthalmic Issues | Other conditions | Ocular motor palsies | – | – |
Ophthalmic Issues | Initial evaluation | Initial evaluation | – | – |
ICU Medications | Icu medications | ICU Medications | – | ICU Medications |
ACLS | Pulmonary edema, hypotension or shock | ACLS pulmonary edema, hypotension or shock algorithm | ACLS pulmonary edema, hypotension or shock algorithm | – |
ACLS | Tachycardia | ACLS tachycardia algorithm | ACLS tachycardia algorithm | – |
ACLS | Bradycardia | ACLS bradycardia algorithm | ACLS bradycardia algorithm | – |
ACLS | Vf/pulseless vt, asystole, & pea | ACLS VF/Pulseless VT, asystole, & PEA algorithm | ACLS VF/Pulseless VT, asystole, & PEA algorithm | – |
Quick References | Chest imaging patterns | Chest Imaging Patterns | – | Chest Imaging Patterns |
Quick References | Peripheral smear findings | Peripheral Smear Findings | – | Peripheral Smear Findings |
Quick References | Heparin for thromboembolism | Heparin for Thromboembolism | – | Heparin for Thromboembolism |
Quick References | Heparin for acs | Heparin for ACS | – | Heparin for ACS |
Quick References | Warfarin loading nomogram | Warfarin Loading Nomogram | – | Warfarin Loading Nomogram |
Quick References | Warfarin-heparin overlap therapy | Warfarin-Heparin Overlap Therapy | – | Common Warfarin-Drug Interactions |